US20220348723A1 - Rapid hydrosilylation cure composition - Google Patents

Rapid hydrosilylation cure composition Download PDF

Info

Publication number
US20220348723A1
US20220348723A1 US17/761,269 US202017761269A US2022348723A1 US 20220348723 A1 US20220348723 A1 US 20220348723A1 US 202017761269 A US202017761269 A US 202017761269A US 2022348723 A1 US2022348723 A1 US 2022348723A1
Authority
US
United States
Prior art keywords
composition
range
weight
alkenyl
sio
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
US17/761,269
Other versions
US11492449B1 (en
Inventor
Michelle Cummings
Joel P. McDonald
Jason D. Suhr
Bradley W. Tuft
Brian Clark
Rachel Rademacher
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dow Global Technologies LLC
Dow Silicones Corp
Original Assignee
Dow Global Technologies LLC
Dow Silicones Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dow Global Technologies LLC, Dow Silicones Corp filed Critical Dow Global Technologies LLC
Priority to US17/761,269 priority Critical patent/US11492449B1/en
Assigned to DOW GLOBAL TECHNOLOGIES LLC reassignment DOW GLOBAL TECHNOLOGIES LLC ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: MCDONALD, JOEL P., CLARK, BRIAN
Assigned to DOW SILICONES CORPORATION reassignment DOW SILICONES CORPORATION ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: RADEMACHER, Rachel, CUMMINGS, MICHELLE, SUHR, JASON D., TUFT, Bradley W.
Publication of US20220348723A1 publication Critical patent/US20220348723A1/en
Application granted granted Critical
Publication of US11492449B1 publication Critical patent/US11492449B1/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08LCOMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L83/00Compositions of macromolecular compounds obtained by reactions forming in the main chain of the macromolecule a linkage containing silicon with or without sulfur, nitrogen, oxygen or carbon only; Compositions of derivatives of such polymers
    • C08L83/04Polysiloxanes
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G77/00Macromolecular compounds obtained by reactions forming a linkage containing silicon with or without sulfur, nitrogen, oxygen or carbon in the main chain of the macromolecule
    • C08G77/04Polysiloxanes
    • C08G77/12Polysiloxanes containing silicon bound to hydrogen
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G77/00Macromolecular compounds obtained by reactions forming a linkage containing silicon with or without sulfur, nitrogen, oxygen or carbon in the main chain of the macromolecule
    • C08G77/04Polysiloxanes
    • C08G77/20Polysiloxanes containing silicon bound to unsaturated aliphatic groups
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B29WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29CSHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
    • B29C35/00Heating, cooling or curing, e.g. crosslinking or vulcanising; Apparatus therefor
    • B29C35/02Heating or curing, e.g. crosslinking or vulcanizing during moulding, e.g. in a mould
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G77/00Macromolecular compounds obtained by reactions forming a linkage containing silicon with or without sulfur, nitrogen, oxygen or carbon in the main chain of the macromolecule
    • C08G77/04Polysiloxanes
    • C08G77/06Preparatory processes
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G77/00Macromolecular compounds obtained by reactions forming a linkage containing silicon with or without sulfur, nitrogen, oxygen or carbon in the main chain of the macromolecule
    • C08G77/04Polysiloxanes
    • C08G77/14Polysiloxanes containing silicon bound to oxygen-containing groups
    • C08G77/16Polysiloxanes containing silicon bound to oxygen-containing groups to hydroxyl groups
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G77/00Macromolecular compounds obtained by reactions forming a linkage containing silicon with or without sulfur, nitrogen, oxygen or carbon in the main chain of the macromolecule
    • C08G77/70Siloxanes defined by use of the MDTQ nomenclature
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09DCOATING COMPOSITIONS, e.g. PAINTS, VARNISHES OR LACQUERS; FILLING PASTES; CHEMICAL PAINT OR INK REMOVERS; INKS; CORRECTING FLUIDS; WOODSTAINS; PASTES OR SOLIDS FOR COLOURING OR PRINTING; USE OF MATERIALS THEREFOR
    • C09D183/00Coating compositions based on macromolecular compounds obtained by reactions forming in the main chain of the macromolecule a linkage containing silicon, with or without sulfur, nitrogen, oxygen, or carbon only; Coating compositions based on derivatives of such polymers
    • C09D183/04Polysiloxanes
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B29WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29KINDEXING SCHEME ASSOCIATED WITH SUBCLASSES B29B, B29C OR B29D, RELATING TO MOULDING MATERIALS OR TO MATERIALS FOR MOULDS, REINFORCEMENTS, FILLERS OR PREFORMED PARTS, e.g. INSERTS
    • B29K2083/00Use of polymers having silicon, with or without sulfur, nitrogen, oxygen, or carbon only, in the main chain, as moulding material
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G77/00Macromolecular compounds obtained by reactions forming a linkage containing silicon with or without sulfur, nitrogen, oxygen or carbon in the main chain of the macromolecule
    • C08G77/80Siloxanes having aromatic substituents, e.g. phenyl side groups

Definitions

  • the present invention relates to a composition of polyorganosiloxanes.
  • Hydrosilylation reaction compositions undergo hydrosilylation reactions to form cured compositions.
  • Hydrosilylation reaction composition are commonly used in many different applications including in forming coatings and molded parts. In many of these applications there is benefit to rapidly curing the composition.
  • reactive injection molding applications can utilize hydrosilylation reaction compositions to form molded parts in a semi-continuous process where a rapid curing of the composition in the mold can speed up the entire process.
  • Reactive injection molding processes require introducing reactants into a mold where the reactants crosslink to form a polymeric article in the shape of the mold, followed by removal of the crosslinked polymeric article from the mold and then injecting the mold with new reactants to form another crosslinked polymeric article.
  • speed of the crosslinking reaction in the mold is important because it dictates the required residence time of a part in the mold, which typically dictates the rate of manufacture. Residence times for a part in a mold during hydrosilylation reactive injection molding process typically are up to five minutes. It is desirable to identify how to speed the hydrosilylation reaction for reactions used in reactive injection molding in order to minimize the residence time in a mold during cure.
  • One way to decrease residence time in the mold during reactive injection molding of the hydrosilylation reaction composition is to remove the molded article before the hydrosilylation reaction is complete. However, if the process removes molded articles before they are sufficiently reacted there can be dimensional inconsistencies and/or mechanical property variations from part to part. Compositions that are reacting (curing) free of mold constraints can expand or contract as the reaction proceeds. Additionally, incompletely cured parts subjected to mechanical stresses result in undesirable deformation as crosslinking continues outside the mold. Therefore, it is desirable to decrease mold residence time by decreasing the time needed to cure sufficiently to maintain dimensional integrity and consistent mechanical properties once removed from the mold.
  • T90 the time needed to achieve 90% of the cured composition's strength relative to the composition strength of a 10 minute cure (twice the highest typical residence time in a mold). After 10 minutes of cure time the composition usually has achieved near constant strength. At 90% of that strength the composition should have sufficient dimensional integrity and mechanical property consistency to remove from a mold.
  • Typical hydrosilylation reaction compositions used in reactive injection molding comprise either a linear or a resinous silyl hydride functionalized crosslinker in combination with a linear and/or resinous alkenyl functionalized polyorganosiloxane and a hydrosilylation reaction catalyst.
  • Hydrosilylation reactions occur between vinyl functionalized reactants and crosslinkers containing multiple Si—H functionalities and utilize a hydrosilylation reaction catalyst (typically, a platinum catalyst).
  • a hydrosilylation reaction catalyst typically, a platinum catalyst.
  • Increasing the concentration of hydrosilylation catalyst can increase the rate of reaction. However, increased catalyst concentration also tends to increase the yellowing in the resulting molded article, which is undesirable for clear and colorless optical articles.
  • T90 Another option for reducing T90 is to increase the concentration of SiH functionality relative to vinyl functionality (that is, increase the concentration of crosslinker functionality).
  • concentration of SiH functionality relative to vinyl functionality
  • crosslinker functionality increases the amount of crosslinker to increase SiH functionality results in a reduction in article clarity, which is also undesirable for clear and colorless optical articles.
  • T90 for a hydrosilylation reaction composition without increasing the concentration of catalyst or increasing the concentration of crosslinker functionalities relative to alkenyl functionalities in the composition. It is further desirable to achieve such a reduction of T90 while maintaining or increasing the strength of the resulting cured composition after 10 minutes of curing.
  • the composition of the present invention solves the problem of reducing T90 for a hydrosilylation reaction without increasing the concentration of catalyst or increasing the concentration of crosslinker functionalities relative to alkenyl functionalities in the composition. Moreover, the present invention solves the problem of reducing the T90 while maintaining or increasing the strength of the resulting cured composition after 10 minutes of curing. Even more, the present invention is capable of solving this problem for compositions where the molar ratio of SiH to alkenyl functionality ranging from 1.2 or more to 1.6 or less, even 1.7 or less and even 2.2 or less, which makes the invention applicable to compositions suitable for a range of target final cured strengths.
  • “strength” of a cured composition is measured by torque-modulus, where a higher torque-modulus corresponds to a higher strength. Measure torque-modulus according to ASTM D5289 at 150 degrees Celsius (° C.) for a 10 minute reaction period. Hence, herein, determine T90 from a plot of the strength (torque-modulus) of a composition as it cures at 150 degrees Celsius (° C.) for a period of 10 minutes. T90 is the time at which the composition reaches 90% of the strength the composition has at 10 minutes. In particular, measure torque-modulus using a moving die rheometer (MDR) (Alpha Technologies MDR-2000).
  • MDR moving die rheometer
  • MylarTM is a trademark of DUPONT Teijin Films US.
  • MylarTM is a trademark of DUPONT Teijin Films US.
  • MDR platens that are at a steady state of 150° C. for testing.
  • MDR platens that are at a steady state of 150° C. for testing.
  • MDR platens that are at a steady state of 150° C. for testing.
  • MDR platens that are at a steady state of 150° C. for testing.
  • MDR platens that are at a steady state of 150° C. for testing.
  • the present invention offers these improvements over typical commonly used hydrosilylation reaction compositions comprising a blend of linear and resinous alkenyl functional polyorganosiloxanes in combination with either a linear or resinous silyl hydride functional polyorganosiloxane.
  • the present invention is a result of discovering that using a blend of linear and resinous alkenyl functional polyorganosiloxanes in combination with a blend of resinous silyl hydride functional polyorganosiloxane and a linear silyl hydride functional polyorganosiloxane having a particular ratio of D and D H units (defined below) results in a shorter T90 for the composition and equal or greater strength of the fully cured composition than compositions comprising only resinous or only polymeric silyl hydride functional polyorganosiloxanes, or even using blends of linear and resinous silyl hydride functional polyorganosiloxanes having a molar ratio of D and D H units outside the particular ratio range.
  • silyl hydride (SiH) group to alkenyl group mole-ratios in the composition and at equal catalyst concentrations.
  • SiH silyl hydride
  • Use of a linear silyl hydride functional polyorganosiloxane to both increase reaction rate and maintain or increase strength of a fully cured composition is especially surprising because introducing or increasing the concentration of linear polyorganosiloxanes typically would be expected to reduce strength of a cured composition and even slow the curing rate.
  • the linear polyorganosiloxane increases the rate of cure to 90% of the composition's 10 minute strength (decreases T90) while either maintaining or increasing the 10 minute strength of the cured composition.
  • compositions of the present invention also can produce a clear and colorless cured composition in addition to decreasing T90 and at least maintaining the strength of the fully cured composition.
  • the key to the present invention is in the use of a blend of linear and resinous silyl hydride functional polyorganosiloxanes where the linear silyl hydride has a particular D/D H molar ratio.
  • the blend comprises, or consists of, a resinous silyl hydride functional polyorganosiloxane in combination with a linear silyl hydride functional polyorganosiloxane comprising primarily D units having the formula (R′ 2 SiO 2/2 ) and D H units having the formula (R′′HSiO 2/2 ), where R′ is independently in each occurrence selected from a group consisting of phenyl and C 1-8 alkyl groups while R′′ is independently in each occurrence selected from a group consisting of hydrogen and C 1-8 alkyl groups, and wherein the molar ratio of D/D H units is greater than 2.0, preferably 2.2 or more and at the same time less than 14.0, typically 13.5 or less, 11 or less, 10 or less, 9 or less, even 8
  • the present invention is a composition comprising: (A) a blend of alkenyl functionalized polyorganosiloxanes, the blend consisting of: (i) a linear alkenyl functionalized polyorganosiloxane having the following formula:
  • each (R 3 SiO 1/2 ) unit is selected from C 1-8 terminal alkenyl groups; subscript a has a value in a range of 0.333 to 0.999; and wherein the linear alkenyl functionalized polyorganosiloxane has a weight-average molecular weight of 260-155,000 Daltons as determined by gel permeation chromatography (GPC); and (ii) a resinous alkenyl functionalized polyorganosiloxane having the following formula:
  • R groups in each molecule are selected from C 1-8 terminal alkenyl groups; subscript b has a value in a range of 0.35-0.55; subscript c has a value in a range of 0.46-0.55; subscript d has a value in a range of 0.04 to 0.11; where the sum of subscripts b, c and d is one; the weight-average molecular weight of the resinous alkenyl functionalized polyorganosiloxane is in a range of 3,000 to 30,000 Daltons as determined by GPC; where the total concentration of C 1-8 terminal alkenyl groups in the blend of alkenyl functionalized polyorganosiloxanes is in a range of 2.5 to 13.5 mole-percent relative to total moles of polyorganosiloxanes in the blend of alkenyl functionalized polyorganosiloxanes; and (B) a blend of silyl hydride functionalized polyorganosiloxanes, the blend consisting of:
  • the sum of subscripts e and f is in a range of 0.50 to 0.999; the ratio of subscripts e/f is greater than 2.0 and less than 14.0; wherein the linear silyl hydride functionalized polyorganosiloxane has a silicon hydride concentration in a range of 6 to 45 mole-percent relative to moles of the linear silyl hydride functionalized polyorganosiloxane; and a weight-average molecular weight in a range of 350 to 60,000 Daltons as determined by GPC, and is present at a concentration of more than 10 weight-percent and less than 50 weight-percent of weight of the blend of silyl hydride functionalized polyorganosiloxanes; and (ii) a resinous silyl hydride functionalized polyorganosiloxane having the following formula:
  • subscript g has a value in a range of 0.5 to 0.7
  • subscript h has a value in a range of 0.01 to 0.03
  • subscript i has a value in a range of 0.27 to 0.51 where the sum of subscripts g, h and i is one
  • the resinous silyl hydride functionalized polyorganosiloxane has a silicon hydride concentration in a range of 50 to 75 mole-percent relative to moles of resinous silyl hydride functionalized polyorganosiloxane; and having a weight-average molecular weight in a range of 500 to 1,500 Daltons as determined by GPC
  • C a hydrosilylation catalyst at a concentration of 2 to 6 weight-parts per million weight parts of the composition
  • R is independently in each occurrence selected from a group consisting of phenyl, hydroxyl, C 1-8 alkyl, and C 1-8 terminal alkenyl groups
  • R′ is independently in each occurrence selected
  • the present invention is a method for curing the composition of the first aspect, the method comprising the steps of: (i) providing the composition of the first aspect; and (ii) heating the composition to a temperature in a range of 120 to 220° C.
  • the present invention is useful for preparing cured hydrosilylation products.
  • the present invention is particularly useful for preparing cured hydrosilylation products using an injection molding process.
  • FIG. 1 illustrates the rate of cure curves over a 10 minute cure at 150° C. for compositions comprising: only linear crosslinker (Comparative Example A); only resinous crosslinker (Comparative Example B); and the combination of resinous and linear crosslinker of the present invention (Example 1).
  • the rate of cure is shown as a plot of torque-modulus (composition strength) versus time.
  • Test methods refer to the most recent test method as of the priority date of this document when a date is not indicated with the test method number. References to test methods contain both a reference to the testing society and the test method number. The following test method abbreviations and identifiers apply herein: ASTM refers to ASTM International; EN refers to European Norm; DIN refers to Deutsches Institut für Normung; ISO refers to International Organization for Standards; and CIE refers to International Commission on Illumination standards.
  • Alkyl is a hydrocarbon radical derived from an alkane by removal of a hydrogen atom. “Substituted alkyl” is an alkyl that has an atom other than carbon and hydrogen in place of at least one carbon or hydrogen. Substituted alkyls include alkyl amines and alkyl thiols.
  • Aryl is a radical derived from an aromatic hydrocarbon by removal of a hydrogen atom.
  • Substituted aryl is an aryl that has an atom other than carbon and hydrogen in place of at least one carbon or hydrogen.
  • Terminal alkenyl group refers to an alkenyl group that has a carbon-carbon double bond between a terminal carbon and an adjacent carbon at the end of a carbon chain remote from where the hydrogen atom would have been removed to form the alkenyl group from a corresponding alkene group.
  • allyl groups are terminal alkenyl groups.
  • vinyl groups are also considered terminal alkenyl groups.
  • C x-y refers to molecules having x or more and y or fewer carbon atoms.
  • “Clear” means a material that has more than 80% average transmittance at a wavelength of 400 nanometers using a 3.2 centimeter sample path length as measured according to ASTM D1003 using an ultraviolet-visible (UV-Vis) spectrometer with an integrating sphere.
  • UV-Vis ultraviolet-visible
  • “Colorless” means a material has less than 0.007 ⁇ u′v′ at 3.2 centimeter path length as determined by the CIE 1976 standard.
  • Polysiloxanes comprise multiple siloxane units.
  • Polyorganosiloxanes comprise multiple siloxane units wherein one or more siloxane unit includes an organic functionality.
  • Siloxane units are characterized generally by the designation M, D, T and Q.
  • M generally refers to a siloxane unit having the formula “R ⁇ 3 SiO 1/2 ”.
  • D generally refers to a siloxane unit having the formula R ⁇ 2 SiO 2/2 ′′.
  • T generally refers to a siloxane unit having the formula R ⁇ SiO 3/2 ′′.
  • Q refers to a siloxane unit having the formula “SiO 4/2 ”.
  • R ⁇ is usually independently in each occurrence selected from a group consisting of hydrogen, hydroxyl, alkoxy, or any carbon-bound substituent, including methyl, ethyl, propyl, butyl, pentyl, hexyl and phenyl.
  • a “carbon-bound substituent” is a group that is bound to the silicon atom through a carbon atom.
  • an oxygen atom having a multiple of “1 ⁇ 2” subscript indicates that the oxygen bridges the specified atom to a second atom where the second atom is also specified with an oxygen having a multiple of “1 ⁇ 2” subscript.
  • “(SiO 4/2 )(HO 1/2 )” refers to a Q-type group with a silicon atom bound through a single oxygen to a hydrogen.
  • T90 is the time it takes for the composition to reach 90% of the torque-modulus is has after 10 minutes at 150° C. Measure torque-modulus according to ASTM D5289 at 150 degrees Celsius (° C.) for a 10 minute reaction period.
  • the present invention is a composition comprising: (A) a blend of alkenyl functionalized polyorganosiloxanes comprising: (i) a linear alkenyl functionalized polyorganosiloxane and (ii) a resinous alkenyl functionalized polyorganosiloxane; (B) a blend of silyl hydride functionalized polyorganosiloxanes comprising: (i) a linear silyl hydride functionalized polyorganosiloxane; and (ii) a resinous silyl hydride functionalized polyorganosiloxane; and (C) a hydrosilylation catalyst.
  • the blend of alkenyl functionalized polyorganosiloxanes consists of: (i) a linear alkenyl functionalized polyorganosiloxane; and (ii) a resinous alkenyl functionalized polyorganosiloxane.
  • the structures for each of these alkenyl functionalized polyorganosiloxanes are described below.
  • R groups in the linear and resinous alkenyl functionalized polyorganosiloxanes is such that total concentration of C 1-8 terminal alkenyl groups provided by R groups is in a range of 2.5 to 13.5 mole-percent (mol %) relative to total moles of polyorganosiloxanes in the blend of alkenyl functionalized polyorganosiloxanes (combination of (A)(i) and (A)(ii)).
  • the linear alkenyl functionalized polyorganosiloxane is required in the present invention primarily as a reactive viscosity reducing agent for the composition. Without the linear alkenyl functionalized polyorganosiloxane, the composition viscosity is thick and unusable in injection molding processes. Reactivity in the viscosity reducing agent is important to bind the component into the resulting polymer thereby precluding it from being an extractable in the cured form of the composition.
  • the linear alkenyl functionalized polyorganosiloxane has the following formula:
  • R is independently in each occurrence selected from a group consisting of phenyl, hydroxyl, C 1-8 alkyl, alkoxy, and C 1-8 terminal alkenyl groups; provided that at least one R in each (R 3 SiO 1/2 ) unit is a C 1-8 terminal alkenyl group.
  • the C 1-8 terminal alkenyl group is selected from a group consisting of vinyl, propenyl, butenyl, pentenyl and hexenyl.
  • the C 1-8 terminal alkenyl group is a vinyl group.
  • R′ is independently in each occurrence selected from a group consisting of phenyl, C 1-8 alkyl and alkoxy, groups.
  • the C 1-8 alkyl groups are selected from a group consisting of methyl, ethyl, propyl, butyl, pentyl and hexyl.
  • Subscript a is the average mole-ratio of the (R′ 2 SiO 2/2 ) siloxane units relative to all siloxane units in the molecule and has a value of 0.333 or higher, preferably 0.8 or higher while at the same time has a value of 0.999 or lower.
  • the linear alkenyl functionalized polyorganosiloxane has a weight-averaged molecular weight of 260 Daltons (Da) or more, 300 Da or more, 400 Da or more, 500 Da or more, 1,000 Da or more, 2,000 Da or more, 3,000 Da or more, 4,000 Da or more, 5,000 Da or more, 7,500 Da or more, 10,000 Da or more, 15,000 Da or more, 20,000 Da or more, 25,000 Da or more, even 28,000 Da or more while at the same time has a weight-averaged molecular weight of 155,000 Da or less, preferably 140,000 Da or less, even 130,000 Da or less.
  • Da weight-averaged molecular weight of 260 Daltons (Da) or more, 300 Da or more, 400 Da or more, 500 Da or more, 1,000 Da or more, 2,000 Da or more, 3,000 Da or more, 4,000 Da or more, 5,000 Da or more, 7,500 Da or more, 10,000 Da or more, 15,000 Da or more, 20,000 Da or more, 25,000 Da or more, even
  • Suitable linear alkenyl functionalized polyorganosiloxanes include any one or combination of more than one of those commercially available from Gelest under the names DMS-V03 through DMS-V52.
  • the concentration of the linear alkenyl functionalized polyorganosiloxane (Component (A)(i)) is 25 weight-percent (wt %) or more while at the same time 80 wt % or less based on the weight of the sum of Components (A)(i), (A)(ii), (B)(i) and (B)(iii).
  • the resinous alkenyl functionalized polyorganosiloxane is required in the present invention as a reactive reinforcing agent. Without the resinous alkenyl functionalized polyorganosiloxane, the composition would not cure to a desired strength or toughness for extracting from a mold during a reactive injection molding process.
  • the resinous alkenyl functionalized polyorganosiloxane has the following formula:
  • R is independently in each occurrence selected from a group consisting of phenyl, hydroxyl, C 1-8 alkyl, alkoxy, and C 1-8 terminal alkenyl groups; provided that R is in at least two occurrences in each molecule selected from a group consisting of C 1-8 terminal alkenyl groups.
  • the C 1-8 terminal alkenyl group is selected from a group consisting of vinyl, propenyl, butenyl, pentenyl and hexenyl.
  • the C 1-8 terminal alkenyl group is a vinyl.
  • Subscript b is the average mole-ratio of the (R 3 SiO 1/2 ) siloxane units in the molecule relative to total moles of (R 3 SiO 1/2 ), (SiO 4/2 ) and (HO 1/2 ) units in the molecule. Subscript b has a value in a range of 0.35 to 0.55.
  • Subscript c is the average mole-ratio of the (SiO 4/2 ) siloxane units in the molecule relative to total moles of (R 3 SiO 1/2 ), (SiO 4/2 ) and (HO 1/2 ) units in the molecule. Subscript c has a value in a range of 0.46 to 0.55.
  • Subscript d is the average mole-ratio of (HO 1/2 ) units in the molecule relative to total moles of (R 3 SiO 1/2 ), (SiO 4/2 ) and (HO 1/2 ) units in the molecule.
  • Subscript c has a value of 0.04 or more, even 0.06 or more and at the same time, 0.11 or less.
  • the resinous alkenyl functionalized polyorganosiloxane has a weight-average molecular weight in a range of 3,000 to 30,000 Daltons.
  • Suitable resinous alkenyl functionalized polyorganosiloxanes include those prepared according to U.S. Pat. No. 2,676,182.
  • the resinous alkenyl functionalized polyorganosiloxane can be made by treating a resin copolymer produced by a silica hydrosol capping process with an alkenyl containing endblocking agent.
  • This method preferably includes reacting a silica hydrosol under acidic conditions with a hydrolysable triorganosilane such as trimethylchlorosilane, a siloxanes such as hexamethyldisiloxane, and combinations thereof, and then recovering a copolymer having M-type units and Q-type units including 2-5 wt % hydroxyl groups.
  • the copolymer may be further reacted with an endblocking agents including unsaturated organic groups and an endblocking agent free of aliphatic unsaturation in amounts sufficient to provide 3 to 9 mole-percent (mol %) of unsaturated organofunctional M units in the resin relative to the sum of all siloxane units of the resin.
  • Suitable endblocking agents include silazanes, siloxanes, silanes, and combinations thereof.
  • the resinous alkenyl functionalized polyorganosiloxane can have such a formulation where subscript b is in a range of 0.35 or more, 0.40 or more, even 0.44 or more and at the same time 0.47 or less, even 0.44 or less.
  • a resinous alkenyl functionalized polyorganosiloxane is particularly versatile in the present invention for achieving the reduced T90 while maintaining or increasing final cured modulus over a broad range of silyl hydride to alkenyl molar ratios including from 1.2 to 2.2.
  • Such resins typically further have subscript d in a range of 0.05 or more, 0.06 or more, even 0.07 or more and at the same time 0.11 or less, even 0.09 or less, even 0.08 or less.
  • resinous alkenyl functionalized polyorganosiloxane has such a formulation where subscript b is 0.48 or more, 0.50 or more and at the same time is 0.55 or less, even 0.53 or less, 0.52 or less, 0.51 or less, even 0.50 or less.
  • Such resins typically further have a subscript d in a range of 0.03 or more, 0.04 or more and at the same time 0.11 or less, 0.09 or less, even 0.08 or less.
  • the concentration of the resinous alkenyl functionalized polyorganosiloxane (Component (A)(ii)) is 25 wt % or more while at the same time is 70 wt % or less based on the weight of the sum of Components (A)(i), (A)(ii), (B)(i) and (B)(iii).
  • the blend of silyl-hydride functionalized polyorganosiloxanes consists of: (i) a linear silyl-hydride functionalized polyorganosiloxane; and (ii) a resinous silyl-hydride functionalized polyorganosiloxane.
  • the linear silyl-hydride functionalized polyorganosiloxane is present at a concentration of more than 10 wt %, even 15 wt % or more, 20 wt % or more, even 25 wt % or more while at the same time less than 50 wt %, and can be 45 wt % or less, 40 wt % or less, 35 wt % or less, 30 wt % or less or even 25 wt % or less relative to the weight of the blend of silyl-hydride functionalized polyorganosiloxanes.
  • the balance to 100 wt % is the resinous silyl-hydride functionalized polyorganosiloxane.
  • compositions with blends of silyl-hydride functional polyorganosiloxanes outside of these ranges may selectively achieve a fast T90 value while increasing or maintaining final modulus of the final cured composition, these blend ratios are needed to achieve such performance over silyl hydride-to-alkenyl ratios between 1.2 and 1.6, preferably 1.7, even more preferably 2.2.
  • the molar ratio of silyl hydride hydrogens in the composition to the sum of terminal alkenyl functionality on alkenyl functionalized polyorganosiloxanes in the composition is 1.2 or more, preferably 1.4 or more while at the same time is 2.2 or less, preferably 1.8 or less, even more preferably 1.7 or less, or 1.6 or less. Determine this molar ratio from the structure and concentration of the components included in the composition. If structure and composition are not known, determine the molar ratio using 1 H, 13 C and 29 Si NMR spectroscopy to identify the molar concentration of the functional groups in the composition.
  • the molar ratio of silyl hydride hydrogens to the sum of terminal alkenyl functionality on alkenyl functionalized polyorganosiloxane in the composition is in a range of 1.2 to 2.2.
  • the molar ratio of silyl hydride hydrogens to the sum of terminal alkenyl functionality on alkenyl functionalized polyorganosiloxane in the composition is in a range of 1.2 to 1.7.
  • the linear silyl hydride functionalized polyorganosiloxane offers the surprising synergistic behavior with the other components to provide for a surprisingly reduced T90 while maintaining or increasing final strength of the fully cured composition relative to compositions with Component (B)(i) or Component (B)(ii) alone with Component (A)—compared using compositions having equal SiH:terminal alkenyl group molar ratios.
  • the linear silyl hydride functionalized polyorganosiloxane has the following formula:
  • R′ is independently in each occurrence selected from a group consisting of phenyl, alkoxy and C 1-8 alkyl groups.
  • R′′ is independently in each occurrence selected from a group consisting of hydrogen and C 1-8 alkyl groups, and is preferably hydrogen or methyl, most preferably methyl.
  • Subscript e is the average mole-ratio of the (R′ 2 SiO 2/2 ) siloxane unit (“D”) relative to total siloxane units in the linear silyl hydride functionalized polyorganosiloxane.
  • Subscript f is the average mole-ratio of the (R′′HSiO 2/2 ) siloxane unit (“D H ”) relative to the total number of siloxane units in the linear silyl hydride functionalized polyorganosiloxane.
  • Subscripts e and f each have a value of 0.50 or more while at the same time 0.999 or less.
  • the ratio of subscripts e:f must be 2.0 or more, preferably 2.2 or more, 2.4 or more 2.6 or more, 3.0 or more, even 4.0 or more while at the same time is 14.0 or less, and can be 13.5 or less, 13.1 or less, 13.0 or less, 12.0 or less, 11.0 or less, 10.5 or less, 10.6 or less, even 5.0 or less, or 3.2 or less. It is possible that this ratio range provides an optimal spacing between D and D H units.
  • the linear silyl hydride functionalized polyorganosiloxane has a silicon hydride concentration of 6 mole-percent (mol %) or more while at the same time 45 mol % or less relative to one mole of the linear silyl hydride functionalized polyorganosiloxane.
  • mol % silicon hydride Determine mol % silicon hydride by 1 H, 13 C and 29 Si NMR spectroscopy.
  • the linear silyl hydride functionalized polyorganosiloxane desirably has a weight-average molecular weight of 350 Da or more, preferably 1,500 Da or more while at the same time typically has a weight-average molecular weight of 60,000 Da or less, preferably 25,000 Da or less.
  • Suitable linear silyl hydride functionalized polyorganosiloxanes can be prepared according to the procedures in U.S. Pat. No. 3,722,247. Suitable commercial linear silyl hydride functionalized polyorganosiloxanes include that available as 88466 from Momentive Performance Materials Japan LLC.
  • the concentration of the linear silyl hydride functionalized polyorganosiloxane (Component (B)(i)) is 0.2 wt % or more while at the same time 15 wt % or less based on the weight of the sum of Components (A)(i), (A)(ii), (B)(i) and (B)(iii).
  • the resinous silyl hydride functionalized polyorganosiloxane is necessary to achieve the desired final modulus upon curing the composition of the present invention.
  • the resinous silyl hydride functionalized polyorganosiloxane has the following formula:
  • R′ is independently in each occurrence selected from a group consisting of phenyl, alkoxy, and C 1-8 alkyl groups;
  • R′′′ is independently in each occurrence selected from a group consisting of hydrogen and C 1-8 alkyl groups and is preferably selected from hydrogen and methyl groups.
  • Subscript g is the average mole-ratio of the (R′′′ 2 HSiO 1/2 ) unit relative to all siloxane units in the resinous silyl hydride functionalized polyorganosiloxane. Subscript g has a value of 0.5 or more while at the same time 0.7 or less.
  • Subscript h is the average mole-ratio of the (R′ 2 SiO 2/2 ) unit relative to all siloxane units in the resinous silyl hydride functionalized polyorganosiloxane.
  • Subscript g has a value of 0.2 or more while at the same time 0.03 or less.
  • Subscript i is the average mole-ratio of the (SiO 4/2 ) unit relative to all siloxane units in the resinous silyl hydride functionalized polyorganosiloxane.
  • Subscript g has a value of 0.27 or more while at the same time 0.51 or less.
  • the resinous silyl hydride functionalize polyorganosiloxane has a weight-average molecular weight of 500 Da or more while at the same time 1500 Da or less.
  • Suitable resinous silyl hydride functionalized polyorganosiloxanes can be made according to the methods of U.S. Pat. No. 4,774,310. Suitable commercially available resinous silyl hydride functionalized polyorganosiloxanes include those available under the tradename MQH-9 from Milliken.
  • the resinous silyl hydride functionalized polyorganosiloxane has a silicon hydride concentration in a range of 50 to 75 mole-percent relative to moles of resinous silyl hydride functionalized polyorganosiloxane.
  • the concentration of the resinous silyl hydride functionalized polyorganosiloxane (Component (B)(ii)) is 1.0 wt % or more while at the same time is 10 wt % or less based on the weight of the sum of Components (A)(i), (A)(ii), (B)(i) and (B)(iii).
  • R is desirable for R to be independently in each occurrence selected from a group consisting of methyl, vinyl, and phenyl groups; at the same time or alternatively, for R′ to be independently in each occurrence selected from a group consisting of methyl and phenyl groups; at the same time or alternatively, for R′′ to be methyl; and at the same time or alternatively, for R to be independently in each occurrence selected from a group consisting of hydrogen and methyl.
  • composition of the present invention further comprises a hydrosilylation catalyst (Component C).
  • the hydrosilylation catalyst is desirably present in the composition at a concentration of 2 weight-parts per million (ppm) or more and at the same time 6 ppm or less, preferably 4 ppm or less relative to composition weight.
  • Suitable hydrosilylation catalysts include, without limitation, platinum group metal which includes platinum, rhodium, ruthenium, palladium, osmium, or iridium metal or an organometallic compound thereof and any combination of any two or more thereof.
  • the hydrosilylation catalyst can be platinum compounds and complexes such as platinum (0)-1,3-divinyl-1,1,3,3-tetramethyldisiloxane (Karstedt's catalyst), H 2 PtCl 6 , di- ⁇ .-carbonyl di-. ⁇ .-cyclopentadienyldinickel, platinum-carbonyl complexes, platinum-divinyltetramethyldisiloxane complexes, platinum cyclovinylmethylsiloxane complexes, platinum acetylacetonate (acac), platinum black, platinum compounds such as chloroplatinic acid, chloroplatinic acid hexahydrate, a reaction product of chloroplatinic acid and a monohydric alcohol, platinum bis(ethylacetoacetate), platinum bis(acetylacetonate), platinum dichloride, and complexes of the platinum compounds with olefins or low molecular weight organopolysiloxanes or platinum compounds microen
  • the hydrosilylation catalyst can be part of a solution that includes complexes of platinum with low molecular weight organopolysiloxanes that include 1,3-diethenyl-1,1,3,3-tetramethyldisiloxane complexes with platinum. These complexes may be microencapsulated in a resin matrix.
  • the catalyst can be 1,3-diethenyl-1,1,3,3-tetramethyldisiloxane complex with platinum.
  • Suitable hydrosilylation catalysts include those described in, for example, U.S. Pat. Nos.
  • Component (D) Alcohol
  • composition of the present invention can optionally further comprise one or a combination or more than one acetylenic alcohol.
  • Acetylenic alcohol can be a desirable component in the composition as a crosslinking inhibitor to provide shelf stability to the composition.
  • Suitable acetylenic alcohols include any one or any combination of more than one selected from a group consisting of 2-methyl-3-butyn-2-ol; 3,5-dimethyl-1-hexyn-3-ol; 1-ethynyl-1-cyclohexanol; and phenylbutynol.
  • the concentration of acetylenic alcohol is typically 10 wt % or less, 9 wt % or less, 8 wt % or less, 7 wt % or less, 6 wt % or less, 5 wt % or less, 4 wt % or less, 3 wt % or less, 2 wt % or less, one wt % or less, or even 0.5 wt % or less while at the same time is zero wt % or more and can be 0.001 wt % or more, 0.01 wt % or more, even 0.1 wt % or more based on composition weight. Determine wt % acetylenic alcohol preferably by how much is added in preparing the composition.
  • composition of the present invention can comprise or be free of components in addition to those already mentioned. Suitable such additional components can include any one or any combination of more than one selected from a group consisting of mold release agents, filler, adhesion promoters, heat stabilizers, flame retardants, reactive diluents, and oxidation inhibitors.
  • the composition can contain or be free of silica particles.
  • compositions of the present invention by preparing the blend of alkenyl functionalized polyorganosiloxanes (Component A) and the blend of the silyl hydride functional polyorganosiloxanes (Component B) and then combining those blends together with other components to form the composition.
  • Component A alkenyl functionalized polyorganosiloxanes
  • Component B silyl hydride functional polyorganosiloxanes
  • Component A it is beneficial to prepare the blend of alkenyl functionalized polyorganosiloxanes (Component A) by introducing the resinous alkenyl functionalized polyorganosiloxane as a solution in a solvent, such as xylene, and then stripping the solvent from the blend. Introducing the resin as a solid, such as in flake form, in an effort to prepare Component A makes it difficult to prepare a homogenous blend suitable to achieve the performance described herein.
  • a solvent such as xylene
  • Cure compositions of the present invention by exposing the composition to a temperature for a period of time sufficient to accomplish cure. While cure can occur at a temperature as low as 25° C., it generally would require an undesirable long time to complete curing at 25° C. Typically, it is desirable to heat the composition to a temperature of 120° C. or more, preferably 130° C. or more, 140° C. or more, 150° C. or more, while at the same time a temperature that is generally 220° C. or less, 210° C. or less, 200° C. or less, 190° C. or less, 180° C. or less, even 170° C. or less in order to more rapidly cure the composition. For example, evaluation of T90 requires heating the composition to 150° C. and as FIG. 1 illustrates, composition strength nearly levels off (an indication of complete reaction) within 10 minutes.
  • Suitable methods of mixing components of the present invention to form a composition include adding the component together and agitating with a spatula, a drum roller, a mechanical stirrer, a three-roll mill, a sigma blade mixer, a bread dough mixer or a two-roll mill.
  • Suitable methods for heating the composition to accelerate curing include heating in any manner including heating through processes such as injection molding, encapsulation molding, press molding, dispenser molding, extrusion molding, transfer molding, press vulcanization, centrifugal casting, calendaring, bead application or blow molding.
  • the composition of the present invention offers a means to decrease T90 while maintaining or increasing strength of the fully cured composition without having to increase catalyst or crosslinker concentration. As a result, clarity and colorless aspects of the resulting cured composition can remain high.
  • the present composition can cure with reduced T90 and same or higher final modulus while still achieving a clear and/or colorless cured composition.
  • the low T90 and high final modulus the composition of the present invention provides makes it ideal for injection molding applications.
  • the low T90 and high final modulus allows parts to be released from the mold quicker than compositions having higher T90 values without experiences damage to the part because it is still malleable and curing.
  • the rapid cure and high final modulus also makes the compositions of the present invention useful as coatings sealants, adhesives, mold making, encapsulants, lenses, and lightguides
  • Table 1 lists the materials for the Examples (Exs) and Comparative Examples (Comp Exs). “Me” refers to “methyl”, “Vi” refers to “vinyl”.
  • A1-1 Linear alkenyl functionalized polyorganosiloxane with a molecular formula of: (Me 2 ViSiO 1/2 ) 0.004 (Me 2 SiO 2/2 ) 0.996 . 61000 Daltons weight-average molecular weight; 0.0048 mol % vinyl. Commercially available as “DMS-V41” from Gelest.
  • A1-2 Linear alkenyl functionalized polyorganosiloxane with a molecular formula of: (Me 2 ViSiO 1/2 ) 0.004 (Me 2 SiO 2/2 ) 0.996 . 102000 weight-average molecular weight; 0.0033 mol % vinyl.
  • DMS-V-51 Commercially available as “DMS-V-51” from Gelest.
  • A2-1 Resinous alkenyl functionalized polyorganosiloxane having the following formula: (ViMe 2 SiO 1/2 ) 0.04 (Me 3 SiO 1/2 ) 0.40 (SiO 4/2 ) 0.49 (HO 1/2 ) 0.07 having a weight-average molecular weight of 6630 Daltons and a vinyl content of 0.070 mol %.
  • (ViMe 2 SiO 1/2 ) 0.04 (Me 3 SiO 1/2 ) 0.40 (SiO 4/2 ) 0.49 (HO 1/2 ) 0.07 having a weight-average molecular weight of 6630 Daltons and a vinyl content of 0.070 mol %.
  • A2-2 Resinous alkenyl functionalized polyorganosiloxane having the following formula: (ViMe 2 SiO 1/2 ) 0.09 (Me 3 SiO 1/2 ) 0.42 (SiO 4/2 ) 0.45 (HO 1/2 ) 0.04 having a weight-average molecular weight of 3512 Daltons and a vinyl content of 0.115 mol %.
  • (ViMe 2 SiO 1/2 ) 0.09 (Me 3 SiO 1/2 ) 0.42 (SiO 4/2 ) 0.45 (HO 1/2 ) 0.04 having a weight-average molecular weight of 3512 Daltons and a vinyl content of 0.115 mol %.
  • B1-1 Linear alkenyl functionalized polyorganosiloxane having the following formula: (Me 3 SiO 1/2 ) 0.02 (Me 2 SiO 2/2 ) 0.48 (MeHSiO 2/2 ) 0.50 having 0.708 mol % of H and a D/D H mole ratio of 1. Prepare according to the teachings of U.S. Pat. No. 3,722,247.
  • B1-2 Linear alkenyl functionalized polyorganosiloxane having the following formula: (Me 3 SiO 1/2 ) 0.14 (Me 2 SiO 2/2 ) 0.60 (MeHSiO 2/2 ) 0.26 having 0.361 mol % of H and a D/D H mole ratio of 2.4.
  • B1-6 Linear alkenyl functionalized polyorganosiloxane having the following formula: (Me 3 SiO 1/2 ) 0.02 (Me 2 SiO 2/2 ) 0.91 (MeHSiO 2/2 ) 0.07 having 0.100 mol % of H and a D/D H mole ratio of 13.1.
  • B2 Resinous silyl hydride functionalized polyorganosiloxane having the following formula: (HMe 2 SiO 1/2 ) 0.02 (Me 2 SiO 1/2 ) 0.62 (SiO 4/2 ) 0.30 having 0.950 mol % H.
  • C Karstedt's catalyst Platinum(0)-1,3-divinyl-1,1,3,3-tetramethyldisiloxane. Commercially available from Sigma-Aldrich. D1 Inhibitor 1-ethynyl-1-cyclohexanol. Commercially available from Sigma-Aldrich. D2 Inhibitor 3,5-dimethyl-1-hexyn-3-ol. Commercially available as Surfynol TM 61 (Surfynol is a trademark of Evonik Degussa GmbH).
  • Evaluate optical properties of the formulations in the following manner. Pour a sample of the formulation into a polystyrene cuvette of dimensions 3.2 centimeters by 2 centimeters by 5 centimeters (Konica Minolta, Sensing Plastic Cell CM-A132 Part No. 1870-717). Cure the sample in an oven at 80° C. for 24 hours. Remove the cured sample from the cuvette and post cure at 150° C. for one hour. Measure optical properties of the post-cured sample using a Perkin Elmer Lambda 950 spectrophotometer equipped with a 150 millimeter integrating sphere.
  • spectrophotometers Operate the spectrophotometers at a scan speed of 250 nanometers per minute using a one nanometer slit width over a wavelength range of 200-800 nanometers. Obtain optical transmittance of the samples as described in ASTMD1003. Calculate ⁇ u′v′ from the transmittance spectra as described in CIE 1976 standard. Report transmittance data with reflection losses (Fresnel reflections).
  • Table 1 contains the weight-parts of each component in the formulations for Comparative Example (Comp Ex) A, Comp Ex B and Example (Ex) 1.
  • FIG. 1 provides in illustration form the strength of the composition as the reaction progresses.
  • the large symbol for each set of data corresponds to the T90 value for the run.
  • the formulation when the composition lacks linear silyl hydride functionalized polyorganosiloxane (see Comp Ex B) then the formulation not only has a relatively long T90 but fails to achieve a final strength even close to the other compositions.
  • the composition lacks a resinous silyl hydride functionalized polyorganosiloxane (see Comp Ex A) then the formulation has a relative long T90 even though it eventually reaches a similar composition strength as Ex 1.
  • Ex 1 illustrates that when both the linear and resinous silyl hydride functionalize polyorganosiloxanes are present the composition quickly builds strength and has a relatively short T90.
  • Comp Exs C and D illustrate the effect of increasing catalyst concentration to a composition comprising linear and resinous alkenyl functionalized polyorganosiloxanes and resinous silyl hydride functionalized polyorganosiloxanes.
  • Table 2 presents the weight-parts of each component in Comp Exs C and D as well as the characteristics of the resulting compositions.
  • Comp Ex D contains 3 times the amount of catalyst relative to Comp Ex C and results in a higher aged ⁇ u′v′, corresponding to a reduction in optical quality.
  • Comp Exs E and F illustrate the effect of increasing resinous silyl hydride functionalized polyorganosiloxane (increasing resinous crosslinker concentration).
  • Table 3 presents the weight-parts of each component in Comp Exs E and F and characteristics of the resulting compositions.
  • Increasing resinous crosslinker results in a decreased initial % transmittance at 400 nm and aged ⁇ u′v′, corresponding less transparency.
  • compositions of the present invention upon curing the composition.
  • faster T90 values and equal or greater final modulus values are achieved relative to similar compositions with only resinous silyl-hydride functional crosslinkers over a broad range of silyl hydride-to-alkenyl ratios, demonstrating the surprising effect of adding linear crosslinker has in the present invention.
  • Tables 4-6 present formulations and results for samples with a variety of D/D H ratios at three different silyl hydride-to alkenyl ratios, each using A2-1 as the resinous alkenyl functionalized polyorganosiloxane. Formulations show the weight-parts of each component in the composition.
  • Table 7 presents formulations and results for samples with a variety of D/D H ratios at three different silyl hydride-to-alkenyl ratios, each using A2-2 as the resinous alkenyl functionalized polyorganosiloxane.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Thermal Sciences (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Physics & Mathematics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Wood Science & Technology (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Injection Moulding Of Plastics Or The Like (AREA)
  • Silicon Polymers (AREA)

Abstract

A composition contains a blend of linear and resinous alkenyl functionalized polyorganosiloxanes, a blend of linear and resinous silyl hydride functionalized polyorganosiloxanes, and a hydrosilylation catalyst where the linear silyl hydride functionalized polyorganosiloxanes has a ratio of D/DH that is greater than 2.0 and less than 14, the molar and the ratio of silyl hydride hydrogens to the sum of terminal alkenyl functionality on the alkenyl functionalized polyorganosiloxane is 1.2-2.2.

Description

    BACKGROUND OF THE INVENTION Field of the Invention
  • The present invention relates to a composition of polyorganosiloxanes.
  • INTRODUCTION
  • Hydrosilylation reaction compositions undergo hydrosilylation reactions to form cured compositions. Hydrosilylation reaction composition are commonly used in many different applications including in forming coatings and molded parts. In many of these applications there is benefit to rapidly curing the composition. For example, reactive injection molding applications can utilize hydrosilylation reaction compositions to form molded parts in a semi-continuous process where a rapid curing of the composition in the mold can speed up the entire process. Reactive injection molding processes require introducing reactants into a mold where the reactants crosslink to form a polymeric article in the shape of the mold, followed by removal of the crosslinked polymeric article from the mold and then injecting the mold with new reactants to form another crosslinked polymeric article. For reactive injection molding processes, speed of the crosslinking reaction in the mold is important because it dictates the required residence time of a part in the mold, which typically dictates the rate of manufacture. Residence times for a part in a mold during hydrosilylation reactive injection molding process typically are up to five minutes. It is desirable to identify how to speed the hydrosilylation reaction for reactions used in reactive injection molding in order to minimize the residence time in a mold during cure.
  • One way to decrease residence time in the mold during reactive injection molding of the hydrosilylation reaction composition is to remove the molded article before the hydrosilylation reaction is complete. However, if the process removes molded articles before they are sufficiently reacted there can be dimensional inconsistencies and/or mechanical property variations from part to part. Compositions that are reacting (curing) free of mold constraints can expand or contract as the reaction proceeds. Additionally, incompletely cured parts subjected to mechanical stresses result in undesirable deformation as crosslinking continues outside the mold. Therefore, it is desirable to decrease mold residence time by decreasing the time needed to cure sufficiently to maintain dimensional integrity and consistent mechanical properties once removed from the mold. In particular, it is desirable to minimize “T90”—the time needed to achieve 90% of the cured composition's strength relative to the composition strength of a 10 minute cure (twice the highest typical residence time in a mold). After 10 minutes of cure time the composition usually has achieved near constant strength. At 90% of that strength the composition should have sufficient dimensional integrity and mechanical property consistency to remove from a mold.
  • One option for minimizing T90 is by increasing the concentration of reaction catalyst in the composition. Typical hydrosilylation reaction compositions used in reactive injection molding comprise either a linear or a resinous silyl hydride functionalized crosslinker in combination with a linear and/or resinous alkenyl functionalized polyorganosiloxane and a hydrosilylation reaction catalyst. Hydrosilylation reactions occur between vinyl functionalized reactants and crosslinkers containing multiple Si—H functionalities and utilize a hydrosilylation reaction catalyst (typically, a platinum catalyst). Increasing the concentration of hydrosilylation catalyst can increase the rate of reaction. However, increased catalyst concentration also tends to increase the yellowing in the resulting molded article, which is undesirable for clear and colorless optical articles.
  • Another option for reducing T90 is to increase the concentration of SiH functionality relative to vinyl functionality (that is, increase the concentration of crosslinker functionality). However, increasing the amount of crosslinker to increase SiH functionality results in a reduction in article clarity, which is also undesirable for clear and colorless optical articles.
  • It is desirable to reduce T90 for a hydrosilylation reaction composition without increasing the concentration of catalyst or increasing the concentration of crosslinker functionalities relative to alkenyl functionalities in the composition. It is further desirable to achieve such a reduction of T90 while maintaining or increasing the strength of the resulting cured composition after 10 minutes of curing.
  • BRIEF SUMMARY OF THE INVENTION
  • The composition of the present invention solves the problem of reducing T90 for a hydrosilylation reaction without increasing the concentration of catalyst or increasing the concentration of crosslinker functionalities relative to alkenyl functionalities in the composition. Moreover, the present invention solves the problem of reducing the T90 while maintaining or increasing the strength of the resulting cured composition after 10 minutes of curing. Even more, the present invention is capable of solving this problem for compositions where the molar ratio of SiH to alkenyl functionality ranging from 1.2 or more to 1.6 or less, even 1.7 or less and even 2.2 or less, which makes the invention applicable to compositions suitable for a range of target final cured strengths.
  • Herein, “strength” of a cured composition is measured by torque-modulus, where a higher torque-modulus corresponds to a higher strength. Measure torque-modulus according to ASTM D5289 at 150 degrees Celsius (° C.) for a 10 minute reaction period. Hence, herein, determine T90 from a plot of the strength (torque-modulus) of a composition as it cures at 150 degrees Celsius (° C.) for a period of 10 minutes. T90 is the time at which the composition reaches 90% of the strength the composition has at 10 minutes. In particular, measure torque-modulus using a moving die rheometer (MDR) (Alpha Technologies MDR-2000). Place a 50 micrometer thick Mylar™ polyester film on a weighing tray on a digital scale (Mylar™ is a trademark of DUPONT Teijin Films US). Weigh approximately 4 grams of a formulation promptly after mixing all of the components together onto the Mylar polyester film. Cover the formulation on the Mylar polyester film with an additional layer of 50 micrometer thick Mylar polyester film and transfer immediately to MDR platens that are at a steady state of 150° C. for testing. Close the platens and oscillate the bottom platen in a 1° arc throughout the test. Monitor the torque-modulus for 10 minutes at 150° C. to obtain a plot of the torque-modulus for a sample.
  • The present invention offers these improvements over typical commonly used hydrosilylation reaction compositions comprising a blend of linear and resinous alkenyl functional polyorganosiloxanes in combination with either a linear or resinous silyl hydride functional polyorganosiloxane. Surprisingly, the present invention is a result of discovering that using a blend of linear and resinous alkenyl functional polyorganosiloxanes in combination with a blend of resinous silyl hydride functional polyorganosiloxane and a linear silyl hydride functional polyorganosiloxane having a particular ratio of D and DH units (defined below) results in a shorter T90 for the composition and equal or greater strength of the fully cured composition than compositions comprising only resinous or only polymeric silyl hydride functional polyorganosiloxanes, or even using blends of linear and resinous silyl hydride functional polyorganosiloxanes having a molar ratio of D and DH units outside the particular ratio range. The comparison is at equal silyl hydride (SiH) group to alkenyl group mole-ratios in the composition and at equal catalyst concentrations. Use of a linear silyl hydride functional polyorganosiloxane to both increase reaction rate and maintain or increase strength of a fully cured composition is especially surprising because introducing or increasing the concentration of linear polyorganosiloxanes typically would be expected to reduce strength of a cured composition and even slow the curing rate. However, in the particular range of D/DH molar ratio of the presently claimed invention, the linear polyorganosiloxane increases the rate of cure to 90% of the composition's 10 minute strength (decreases T90) while either maintaining or increasing the 10 minute strength of the cured composition.
  • The compositions of the present invention also can produce a clear and colorless cured composition in addition to decreasing T90 and at least maintaining the strength of the fully cured composition.
  • The key to the present invention is in the use of a blend of linear and resinous silyl hydride functional polyorganosiloxanes where the linear silyl hydride has a particular D/DH molar ratio. The blend comprises, or consists of, a resinous silyl hydride functional polyorganosiloxane in combination with a linear silyl hydride functional polyorganosiloxane comprising primarily D units having the formula (R′2SiO2/2) and DH units having the formula (R″HSiO2/2), where R′ is independently in each occurrence selected from a group consisting of phenyl and C1-8 alkyl groups while R″ is independently in each occurrence selected from a group consisting of hydrogen and C1-8 alkyl groups, and wherein the molar ratio of D/DH units is greater than 2.0, preferably 2.2 or more and at the same time less than 14.0, typically 13.5 or less, 11 or less, 10 or less, 9 or less, even 8 or less.
  • In a first aspect, the present invention is a composition comprising: (A) a blend of alkenyl functionalized polyorganosiloxanes, the blend consisting of: (i) a linear alkenyl functionalized polyorganosiloxane having the following formula:

  • (R3SiO1/2)1−a(R′2SiO2/2)a
  • where: at least one R in each (R3SiO1/2) unit is selected from C1-8 terminal alkenyl groups; subscript a has a value in a range of 0.333 to 0.999; and wherein the linear alkenyl functionalized polyorganosiloxane has a weight-average molecular weight of 260-155,000 Daltons as determined by gel permeation chromatography (GPC); and (ii) a resinous alkenyl functionalized polyorganosiloxane having the following formula:

  • (R3SiO1/2)b(SiO4/2)c(HO1/2)d
  • where: at least two R groups in each molecule are selected from C1-8 terminal alkenyl groups; subscript b has a value in a range of 0.35-0.55; subscript c has a value in a range of 0.46-0.55; subscript d has a value in a range of 0.04 to 0.11; where the sum of subscripts b, c and d is one; the weight-average molecular weight of the resinous alkenyl functionalized polyorganosiloxane is in a range of 3,000 to 30,000 Daltons as determined by GPC; where the total concentration of C1-8 terminal alkenyl groups in the blend of alkenyl functionalized polyorganosiloxanes is in a range of 2.5 to 13.5 mole-percent relative to total moles of polyorganosiloxanes in the blend of alkenyl functionalized polyorganosiloxanes; and (B) a blend of silyl hydride functionalized polyorganosiloxanes, the blend consisting of: (i) a linear silyl hydride functionalized polyorganosiloxane having the following formula:

  • (R′3SiO1/2)1−(e+f)(R′2SiO2/2)e(R″HSiO2/2)f
  • where: the sum of subscripts e and f is in a range of 0.50 to 0.999; the ratio of subscripts e/f is greater than 2.0 and less than 14.0; wherein the linear silyl hydride functionalized polyorganosiloxane has a silicon hydride concentration in a range of 6 to 45 mole-percent relative to moles of the linear silyl hydride functionalized polyorganosiloxane; and a weight-average molecular weight in a range of 350 to 60,000 Daltons as determined by GPC, and is present at a concentration of more than 10 weight-percent and less than 50 weight-percent of weight of the blend of silyl hydride functionalized polyorganosiloxanes; and (ii) a resinous silyl hydride functionalized polyorganosiloxane having the following formula:

  • (R′″2HSiO1/2)g(R′2SiO2/2)h(SiO4/2)i
  • where: subscript g has a value in a range of 0.5 to 0.7; subscript h has a value in a range of 0.01 to 0.03; subscript i has a value in a range of 0.27 to 0.51 where the sum of subscripts g, h and i is one; wherein the resinous silyl hydride functionalized polyorganosiloxane has a silicon hydride concentration in a range of 50 to 75 mole-percent relative to moles of resinous silyl hydride functionalized polyorganosiloxane; and having a weight-average molecular weight in a range of 500 to 1,500 Daltons as determined by GPC; and (C) a hydrosilylation catalyst at a concentration of 2 to 6 weight-parts per million weight parts of the composition; wherein: R is independently in each occurrence selected from a group consisting of phenyl, hydroxyl, C1-8 alkyl, and C1-8 terminal alkenyl groups; R′ is independently in each occurrence selected from a group consisting of phenyl and C1-8 alkyl groups; R″ and R′″ independently in each occurrence selected from a group consisting of hydrogen and C1-8 alkyl groups; subscripts a-i are mole-ratios for the corresponding siloxane units relative to total siloxane units in the molecule; and the concentration of Component (A)(i) is in a range of 25 to 80 weight-percent; Component (A)(ii) is in a range of 25 to 70 weight-percent; Component (B)(i) is in a range of 0.2 to 15 weight-percent; and Component (B)(ii) is in a range of 1.0 to 10 weight-percent; with weight-percent relative to combined weight of Components (A)(i), (A)(ii), (B)(i) and (B)(ii); and the molar ratio of silyl hydride hydrogens to the sum of terminal alkenyl functionality on alkenyl functionalized polyorganosiloxane in the composition is in a range of 1.2 to 2.2.
  • In a second aspect, the present invention is a method for curing the composition of the first aspect, the method comprising the steps of: (i) providing the composition of the first aspect; and (ii) heating the composition to a temperature in a range of 120 to 220° C.
  • The present invention is useful for preparing cured hydrosilylation products. The present invention is particularly useful for preparing cured hydrosilylation products using an injection molding process.
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • FIG. 1 illustrates the rate of cure curves over a 10 minute cure at 150° C. for compositions comprising: only linear crosslinker (Comparative Example A); only resinous crosslinker (Comparative Example B); and the combination of resinous and linear crosslinker of the present invention (Example 1). The rate of cure is shown as a plot of torque-modulus (composition strength) versus time.
  • DETAILED DESCRIPTION OF THE INVENTION
  • Test methods refer to the most recent test method as of the priority date of this document when a date is not indicated with the test method number. References to test methods contain both a reference to the testing society and the test method number. The following test method abbreviations and identifiers apply herein: ASTM refers to ASTM International; EN refers to European Norm; DIN refers to Deutsches Institut für Normung; ISO refers to International Organization for Standards; and CIE refers to International Commission on Illumination standards.
  • Materials identified only by a product name or tradename refer to the material sold under that product name or tradename at the priority filing date of this document unless otherwise stated herein.
  • “Multiple” means two or more. “And/or” means “and, or as an alternative”. All ranges include endpoints unless otherwise indicated.
  • “Alkyl” is a hydrocarbon radical derived from an alkane by removal of a hydrogen atom. “Substituted alkyl” is an alkyl that has an atom other than carbon and hydrogen in place of at least one carbon or hydrogen. Substituted alkyls include alkyl amines and alkyl thiols.
  • “Aryl” is a radical derived from an aromatic hydrocarbon by removal of a hydrogen atom. “Substituted aryl” is an aryl that has an atom other than carbon and hydrogen in place of at least one carbon or hydrogen.
  • “Terminal alkenyl group” refers to an alkenyl group that has a carbon-carbon double bond between a terminal carbon and an adjacent carbon at the end of a carbon chain remote from where the hydrogen atom would have been removed to form the alkenyl group from a corresponding alkene group. For example, allyl groups are terminal alkenyl groups. For avoidance of doubt, vinyl groups are also considered terminal alkenyl groups.
  • “Cx-y” refers to molecules having x or more and y or fewer carbon atoms.
  • “Clear” means a material that has more than 80% average transmittance at a wavelength of 400 nanometers using a 3.2 centimeter sample path length as measured according to ASTM D1003 using an ultraviolet-visible (UV-Vis) spectrometer with an integrating sphere.
  • “Colorless” means a material has less than 0.007 Δu′v′ at 3.2 centimeter path length as determined by the CIE 1976 standard.
  • Polysiloxanes comprise multiple siloxane units. Polyorganosiloxanes comprise multiple siloxane units wherein one or more siloxane unit includes an organic functionality. Siloxane units are characterized generally by the designation M, D, T and Q. M generally refers to a siloxane unit having the formula “R 3SiO1/2”. D generally refers to a siloxane unit having the formula R 2SiO2/2″. T generally refers to a siloxane unit having the formula RSiO3/2″. Q refers to a siloxane unit having the formula “SiO4/2”. R is usually independently in each occurrence selected from a group consisting of hydrogen, hydroxyl, alkoxy, or any carbon-bound substituent, including methyl, ethyl, propyl, butyl, pentyl, hexyl and phenyl. A “carbon-bound substituent” is a group that is bound to the silicon atom through a carbon atom. Notably, an oxygen atom having a multiple of “½” subscript indicates that the oxygen bridges the specified atom to a second atom where the second atom is also specified with an oxygen having a multiple of “½” subscript. For example, “(SiO4/2)(HO1/2)” refers to a Q-type group with a silicon atom bound through a single oxygen to a hydrogen.
  • Determine average molar amounts and average mole-ratios of siloxane units and (HO1/2) units using 29Si, 13C and 1H NMR using, for example, the method described in The Analytical Chemistry of Silicones, Smith, A. Lee, ed., John Wiley & Sons: New York, 1991, p. 347ff. These values are typically stated as subscripts after the associated siloxane unit.
  • Identity of organic groups on a polyorganosiloxane can be done using Silicon 29 Nuclear Magnetic Spectroscopy (29Si NMR), Carbon 13 Nuclear Magnetic Spectroscopy (13C NMR), proton Nuclear Magnetic Spectroscopy (1H NMR), titration, or Fourier Transform Infrared Spectroscopy (FTIR).
  • Molecular weight for polysiloxanes are reported herein as weight-average molecular weight as determined by triple detection gel permeation chromatography (GPC) using a Waters 515 pump, a Waters 717 autosampler and Waters 2410 differential refractometer. Conduct separation with two (300 millimeter (mm) by 7.5 mm) Polymer Laboratories PLgel 5 micrometer (μm) Mixed-C columns (molecular weight separation range of 200 to 2,000,000 Daltons), preceded by a PLgel 5 μm guard column (50 mm by 7.5 mm). Conduct analysis using HPLC grade toluene flowing at 1.0 milliliter (mL) per minute as the eluent, with the columns and detector at 45° C. Prepare the samples in toluene at 5 milligrams per mL concentration, solvate at room temperature for about three hours with occasional shaking, and filter through 0.45 micrometers (μm) polytetrafluoroethylene syringe filters prior to analysis. Use an injection volume of 75 microliters and collect data for 25 minutes. Perform data collection and analysis using ThermoLabsystems Atlas chromatography software and Polymer Laboratories Cirrus GPC software. Determine weight-average molecular weight relative to a calibration curve (3rd order) using polystyrene standards over the molecular weight range of 580 to 2,300,00 Daltons.
  • Determine weight-percent (wt %) of the components in the composition from how much of each component is used to prepare the composition.
  • Determine T90 for a composition as described previously above. “T90” is the time it takes for the composition to reach 90% of the torque-modulus is has after 10 minutes at 150° C. Measure torque-modulus according to ASTM D5289 at 150 degrees Celsius (° C.) for a 10 minute reaction period.
  • The present invention is a composition comprising: (A) a blend of alkenyl functionalized polyorganosiloxanes comprising: (i) a linear alkenyl functionalized polyorganosiloxane and (ii) a resinous alkenyl functionalized polyorganosiloxane; (B) a blend of silyl hydride functionalized polyorganosiloxanes comprising: (i) a linear silyl hydride functionalized polyorganosiloxane; and (ii) a resinous silyl hydride functionalized polyorganosiloxane; and (C) a hydrosilylation catalyst.
  • Component (A)—Blend of Alkenyl Functionalized Polyorganosiloxanes
  • The blend of alkenyl functionalized polyorganosiloxanes consists of: (i) a linear alkenyl functionalized polyorganosiloxane; and (ii) a resinous alkenyl functionalized polyorganosiloxane. The structures for each of these alkenyl functionalized polyorganosiloxanes are described below.
  • Selection of R groups in the linear and resinous alkenyl functionalized polyorganosiloxanes is such that total concentration of C1-8 terminal alkenyl groups provided by R groups is in a range of 2.5 to 13.5 mole-percent (mol %) relative to total moles of polyorganosiloxanes in the blend of alkenyl functionalized polyorganosiloxanes (combination of (A)(i) and (A)(ii)).
  • (A)(i) Linear Alkenyl Functionalize Polyorganosiloxane
  • The linear alkenyl functionalized polyorganosiloxane is required in the present invention primarily as a reactive viscosity reducing agent for the composition. Without the linear alkenyl functionalized polyorganosiloxane, the composition viscosity is thick and unusable in injection molding processes. Reactivity in the viscosity reducing agent is important to bind the component into the resulting polymer thereby precluding it from being an extractable in the cured form of the composition.
  • The linear alkenyl functionalized polyorganosiloxane has the following formula:

  • (R3SiO1/2)1−a(R′2SiO2/2)a
  • R is independently in each occurrence selected from a group consisting of phenyl, hydroxyl, C1-8 alkyl, alkoxy, and C1-8 terminal alkenyl groups; provided that at least one R in each (R3SiO1/2) unit is a C1-8 terminal alkenyl group. Preferably, the C1-8 terminal alkenyl group is selected from a group consisting of vinyl, propenyl, butenyl, pentenyl and hexenyl. Desirably, the C1-8 terminal alkenyl group is a vinyl group.
  • R′ is independently in each occurrence selected from a group consisting of phenyl, C1-8 alkyl and alkoxy, groups. Preferably, the C1-8 alkyl groups are selected from a group consisting of methyl, ethyl, propyl, butyl, pentyl and hexyl.
  • Subscript a is the average mole-ratio of the (R′2SiO2/2) siloxane units relative to all siloxane units in the molecule and has a value of 0.333 or higher, preferably 0.8 or higher while at the same time has a value of 0.999 or lower.
  • The linear alkenyl functionalized polyorganosiloxane has a weight-averaged molecular weight of 260 Daltons (Da) or more, 300 Da or more, 400 Da or more, 500 Da or more, 1,000 Da or more, 2,000 Da or more, 3,000 Da or more, 4,000 Da or more, 5,000 Da or more, 7,500 Da or more, 10,000 Da or more, 15,000 Da or more, 20,000 Da or more, 25,000 Da or more, even 28,000 Da or more while at the same time has a weight-averaged molecular weight of 155,000 Da or less, preferably 140,000 Da or less, even 130,000 Da or less.
  • Suitable linear alkenyl functionalized polyorganosiloxanes include any one or combination of more than one of those commercially available from Gelest under the names DMS-V03 through DMS-V52.
  • The concentration of the linear alkenyl functionalized polyorganosiloxane (Component (A)(i)) is 25 weight-percent (wt %) or more while at the same time 80 wt % or less based on the weight of the sum of Components (A)(i), (A)(ii), (B)(i) and (B)(iii).
  • (A)(ii) Resinous Alkenyl Functionalized Polyorganosiloxane
  • The resinous alkenyl functionalized polyorganosiloxane is required in the present invention as a reactive reinforcing agent. Without the resinous alkenyl functionalized polyorganosiloxane, the composition would not cure to a desired strength or toughness for extracting from a mold during a reactive injection molding process.
  • The resinous alkenyl functionalized polyorganosiloxane has the following formula:

  • (R3SiO1/2)b(SiO4/2)c(HO1/2)d
  • R is independently in each occurrence selected from a group consisting of phenyl, hydroxyl, C1-8 alkyl, alkoxy, and C1-8 terminal alkenyl groups; provided that R is in at least two occurrences in each molecule selected from a group consisting of C1-8 terminal alkenyl groups. Preferably, the C1-8 terminal alkenyl group is selected from a group consisting of vinyl, propenyl, butenyl, pentenyl and hexenyl. Desirably, the C1-8 terminal alkenyl group is a vinyl.
  • Subscript b is the average mole-ratio of the (R3SiO1/2) siloxane units in the molecule relative to total moles of (R3SiO1/2), (SiO4/2) and (HO1/2) units in the molecule. Subscript b has a value in a range of 0.35 to 0.55.
  • Subscript c is the average mole-ratio of the (SiO4/2) siloxane units in the molecule relative to total moles of (R3SiO1/2), (SiO4/2) and (HO1/2) units in the molecule. Subscript c has a value in a range of 0.46 to 0.55.
  • Subscript d is the average mole-ratio of (HO1/2) units in the molecule relative to total moles of (R3SiO1/2), (SiO4/2) and (HO1/2) units in the molecule. Subscript c has a value of 0.04 or more, even 0.06 or more and at the same time, 0.11 or less.
  • The resinous alkenyl functionalized polyorganosiloxane has a weight-average molecular weight in a range of 3,000 to 30,000 Daltons.
  • Suitable resinous alkenyl functionalized polyorganosiloxanes include those prepared according to U.S. Pat. No. 2,676,182. The resinous alkenyl functionalized polyorganosiloxane can be made by treating a resin copolymer produced by a silica hydrosol capping process with an alkenyl containing endblocking agent. This method preferably includes reacting a silica hydrosol under acidic conditions with a hydrolysable triorganosilane such as trimethylchlorosilane, a siloxanes such as hexamethyldisiloxane, and combinations thereof, and then recovering a copolymer having M-type units and Q-type units including 2-5 wt % hydroxyl groups. The copolymer may be further reacted with an endblocking agents including unsaturated organic groups and an endblocking agent free of aliphatic unsaturation in amounts sufficient to provide 3 to 9 mole-percent (mol %) of unsaturated organofunctional M units in the resin relative to the sum of all siloxane units of the resin. Suitable endblocking agents include silazanes, siloxanes, silanes, and combinations thereof.
  • The resinous alkenyl functionalized polyorganosiloxane can have such a formulation where subscript b is in a range of 0.35 or more, 0.40 or more, even 0.44 or more and at the same time 0.47 or less, even 0.44 or less. Such a resinous alkenyl functionalized polyorganosiloxane is particularly versatile in the present invention for achieving the reduced T90 while maintaining or increasing final cured modulus over a broad range of silyl hydride to alkenyl molar ratios including from 1.2 to 2.2. Such resins typically further have subscript d in a range of 0.05 or more, 0.06 or more, even 0.07 or more and at the same time 0.11 or less, even 0.09 or less, even 0.08 or less.
  • Another desirably resinous alkenyl functionalized polyorganosiloxane has such a formulation where subscript b is 0.48 or more, 0.50 or more and at the same time is 0.55 or less, even 0.53 or less, 0.52 or less, 0.51 or less, even 0.50 or less. Such resins typically further have a subscript d in a range of 0.03 or more, 0.04 or more and at the same time 0.11 or less, 0.09 or less, even 0.08 or less.
  • The concentration of the resinous alkenyl functionalized polyorganosiloxane (Component (A)(ii)) is 25 wt % or more while at the same time is 70 wt % or less based on the weight of the sum of Components (A)(i), (A)(ii), (B)(i) and (B)(iii).
  • Component (B)—Blend of Silyl-Hydride Functionalized Polyorganosiloxanes
  • The blend of silyl-hydride functionalized polyorganosiloxanes consists of: (i) a linear silyl-hydride functionalized polyorganosiloxane; and (ii) a resinous silyl-hydride functionalized polyorganosiloxane. The linear silyl-hydride functionalized polyorganosiloxane is present at a concentration of more than 10 wt %, even 15 wt % or more, 20 wt % or more, even 25 wt % or more while at the same time less than 50 wt %, and can be 45 wt % or less, 40 wt % or less, 35 wt % or less, 30 wt % or less or even 25 wt % or less relative to the weight of the blend of silyl-hydride functionalized polyorganosiloxanes. The balance to 100 wt % is the resinous silyl-hydride functionalized polyorganosiloxane. While compositions with blends of silyl-hydride functional polyorganosiloxanes outside of these ranges may selectively achieve a fast T90 value while increasing or maintaining final modulus of the final cured composition, these blend ratios are needed to achieve such performance over silyl hydride-to-alkenyl ratios between 1.2 and 1.6, preferably 1.7, even more preferably 2.2.
  • The molar ratio of silyl hydride hydrogens in the composition to the sum of terminal alkenyl functionality on alkenyl functionalized polyorganosiloxanes in the composition is 1.2 or more, preferably 1.4 or more while at the same time is 2.2 or less, preferably 1.8 or less, even more preferably 1.7 or less, or 1.6 or less. Determine this molar ratio from the structure and concentration of the components included in the composition. If structure and composition are not known, determine the molar ratio using 1H, 13C and 29Si NMR spectroscopy to identify the molar concentration of the functional groups in the composition.
  • Desirably, when subscript b of the resinous alkenyl functionalized polyorganosiloxane is in a range of 0.35 to 0.44 and subscript d is in a range of 0.04 to 0.11, then the molar ratio of silyl hydride hydrogens to the sum of terminal alkenyl functionality on alkenyl functionalized polyorganosiloxane in the composition is in a range of 1.2 to 2.2.
  • Desirably, when subscript b of the resinous alkenyl functionalized polyorganosiloxane is in a range of 0.44 to 0.50 and subscript d is in a range of 0.06 to 0.11, then the molar ratio of silyl hydride hydrogens to the sum of terminal alkenyl functionality on alkenyl functionalized polyorganosiloxane in the composition is in a range of 1.2 to 1.7.
  • (B)(i) Linear Silyl Hydride Functionalize Polyorganosiloxane
  • The linear silyl hydride functionalized polyorganosiloxane offers the surprising synergistic behavior with the other components to provide for a surprisingly reduced T90 while maintaining or increasing final strength of the fully cured composition relative to compositions with Component (B)(i) or Component (B)(ii) alone with Component (A)—compared using compositions having equal SiH:terminal alkenyl group molar ratios.
  • The linear silyl hydride functionalized polyorganosiloxane has the following formula:

  • (R′3SiO1/2)1−(e+f)(R′2SiO2/2)e(R″HSiO2/2)f
  • R′ is independently in each occurrence selected from a group consisting of phenyl, alkoxy and C1-8 alkyl groups.
  • R″ is independently in each occurrence selected from a group consisting of hydrogen and C1-8 alkyl groups, and is preferably hydrogen or methyl, most preferably methyl.
  • Subscript e is the average mole-ratio of the (R′2SiO2/2) siloxane unit (“D”) relative to total siloxane units in the linear silyl hydride functionalized polyorganosiloxane. Subscript f is the average mole-ratio of the (R″HSiO2/2) siloxane unit (“DH”) relative to the total number of siloxane units in the linear silyl hydride functionalized polyorganosiloxane. Subscripts e and f each have a value of 0.50 or more while at the same time 0.999 or less. It has been surprisingly discovered that in order to optimally reduce T90 without increasing the amount of platinum catalyst or the concentration of crosslinkers the ratio of subscripts e:f must be 2.0 or more, preferably 2.2 or more, 2.4 or more 2.6 or more, 3.0 or more, even 4.0 or more while at the same time is 14.0 or less, and can be 13.5 or less, 13.1 or less, 13.0 or less, 12.0 or less, 11.0 or less, 10.5 or less, 10.6 or less, even 5.0 or less, or 3.2 or less. It is possible that this ratio range provides an optimal spacing between D and DH units.
  • The linear silyl hydride functionalized polyorganosiloxane has a silicon hydride concentration of 6 mole-percent (mol %) or more while at the same time 45 mol % or less relative to one mole of the linear silyl hydride functionalized polyorganosiloxane. Determine mol % silicon hydride by 1H, 13C and 29Si NMR spectroscopy.
  • The linear silyl hydride functionalized polyorganosiloxane desirably has a weight-average molecular weight of 350 Da or more, preferably 1,500 Da or more while at the same time typically has a weight-average molecular weight of 60,000 Da or less, preferably 25,000 Da or less.
  • Suitable linear silyl hydride functionalized polyorganosiloxanes can be prepared according to the procedures in U.S. Pat. No. 3,722,247. Suitable commercial linear silyl hydride functionalized polyorganosiloxanes include that available as 88466 from Momentive Performance Materials Japan LLC.
  • The concentration of the linear silyl hydride functionalized polyorganosiloxane (Component (B)(i)) is 0.2 wt % or more while at the same time 15 wt % or less based on the weight of the sum of Components (A)(i), (A)(ii), (B)(i) and (B)(iii).
  • (B)(ii) Resinous Silyl Hydride Functionalized Polyorganosiloxane
  • The resinous silyl hydride functionalized polyorganosiloxane is necessary to achieve the desired final modulus upon curing the composition of the present invention.
  • The resinous silyl hydride functionalized polyorganosiloxane has the following formula:

  • (R′″2HSiO1/2)g(R′2SiO2/2)h(SiO4/2)i
  • R′ is independently in each occurrence selected from a group consisting of phenyl, alkoxy, and C1-8 alkyl groups;
  • R′″ is independently in each occurrence selected from a group consisting of hydrogen and C1-8 alkyl groups and is preferably selected from hydrogen and methyl groups.
  • Subscript g is the average mole-ratio of the (R′″2HSiO1/2) unit relative to all siloxane units in the resinous silyl hydride functionalized polyorganosiloxane. Subscript g has a value of 0.5 or more while at the same time 0.7 or less.
  • Subscript h is the average mole-ratio of the (R′2SiO2/2) unit relative to all siloxane units in the resinous silyl hydride functionalized polyorganosiloxane. Subscript g has a value of 0.2 or more while at the same time 0.03 or less.
  • Subscript i is the average mole-ratio of the (SiO4/2) unit relative to all siloxane units in the resinous silyl hydride functionalized polyorganosiloxane. Subscript g has a value of 0.27 or more while at the same time 0.51 or less.
  • Desirably, the resinous silyl hydride functionalize polyorganosiloxane has a weight-average molecular weight of 500 Da or more while at the same time 1500 Da or less.
  • Suitable resinous silyl hydride functionalized polyorganosiloxanes can be made according to the methods of U.S. Pat. No. 4,774,310. Suitable commercially available resinous silyl hydride functionalized polyorganosiloxanes include those available under the tradename MQH-9 from Milliken.
  • The resinous silyl hydride functionalized polyorganosiloxane has a silicon hydride concentration in a range of 50 to 75 mole-percent relative to moles of resinous silyl hydride functionalized polyorganosiloxane.
  • The concentration of the resinous silyl hydride functionalized polyorganosiloxane (Component (B)(ii)) is 1.0 wt % or more while at the same time is 10 wt % or less based on the weight of the sum of Components (A)(i), (A)(ii), (B)(i) and (B)(iii).
  • In the formulas above for Components (A)(i), (A)(ii), (B)(i) and (B)(ii), it is desirable for R to be independently in each occurrence selected from a group consisting of methyl, vinyl, and phenyl groups; at the same time or alternatively, for R′ to be independently in each occurrence selected from a group consisting of methyl and phenyl groups; at the same time or alternatively, for R″ to be methyl; and at the same time or alternatively, for R to be independently in each occurrence selected from a group consisting of hydrogen and methyl.
  • Component (C)—Hydrosilylation Catalyst
  • The composition of the present invention further comprises a hydrosilylation catalyst (Component C). The hydrosilylation catalyst is desirably present in the composition at a concentration of 2 weight-parts per million (ppm) or more and at the same time 6 ppm or less, preferably 4 ppm or less relative to composition weight.
  • Suitable hydrosilylation catalysts include, without limitation, platinum group metal which includes platinum, rhodium, ruthenium, palladium, osmium, or iridium metal or an organometallic compound thereof and any combination of any two or more thereof. The hydrosilylation catalyst can be platinum compounds and complexes such as platinum (0)-1,3-divinyl-1,1,3,3-tetramethyldisiloxane (Karstedt's catalyst), H2PtCl6, di-μ.-carbonyl di-.π.-cyclopentadienyldinickel, platinum-carbonyl complexes, platinum-divinyltetramethyldisiloxane complexes, platinum cyclovinylmethylsiloxane complexes, platinum acetylacetonate (acac), platinum black, platinum compounds such as chloroplatinic acid, chloroplatinic acid hexahydrate, a reaction product of chloroplatinic acid and a monohydric alcohol, platinum bis(ethylacetoacetate), platinum bis(acetylacetonate), platinum dichloride, and complexes of the platinum compounds with olefins or low molecular weight organopolysiloxanes or platinum compounds microencapsulated in a matrix or core-shell type structure. The hydrosilylation catalyst can be part of a solution that includes complexes of platinum with low molecular weight organopolysiloxanes that include 1,3-diethenyl-1,1,3,3-tetramethyldisiloxane complexes with platinum. These complexes may be microencapsulated in a resin matrix. The catalyst can be 1,3-diethenyl-1,1,3,3-tetramethyldisiloxane complex with platinum. Suitable hydrosilylation catalysts include those described in, for example, U.S. Pat. Nos. 3,159,601; 3,220,972; 3,296,291; 3,419,593; 3,516,946; 3,814,730; 3,989,668; 4,784,879; 5,036,117; and 5,175,325 and EP 0 347 895 B. Microencapsulated hydrosilylation catalysts and methods of preparing them are exemplified in U.S. Pat. Nos. 4,766,176; and 5,017,654.
  • Component (D)—Acetylenic Alcohol
  • The composition of the present invention can optionally further comprise one or a combination or more than one acetylenic alcohol. Acetylenic alcohol can be a desirable component in the composition as a crosslinking inhibitor to provide shelf stability to the composition.
  • Examples of suitable acetylenic alcohols include any one or any combination of more than one selected from a group consisting of 2-methyl-3-butyn-2-ol; 3,5-dimethyl-1-hexyn-3-ol; 1-ethynyl-1-cyclohexanol; and phenylbutynol.
  • The concentration of acetylenic alcohol is typically 10 wt % or less, 9 wt % or less, 8 wt % or less, 7 wt % or less, 6 wt % or less, 5 wt % or less, 4 wt % or less, 3 wt % or less, 2 wt % or less, one wt % or less, or even 0.5 wt % or less while at the same time is zero wt % or more and can be 0.001 wt % or more, 0.01 wt % or more, even 0.1 wt % or more based on composition weight. Determine wt % acetylenic alcohol preferably by how much is added in preparing the composition.
  • Additional Components
  • The composition of the present invention can comprise or be free of components in addition to those already mentioned. Suitable such additional components can include any one or any combination of more than one selected from a group consisting of mold release agents, filler, adhesion promoters, heat stabilizers, flame retardants, reactive diluents, and oxidation inhibitors. The composition can contain or be free of silica particles.
  • Preparing the Composition
  • Preferably, prepare compositions of the present invention by preparing the blend of alkenyl functionalized polyorganosiloxanes (Component A) and the blend of the silyl hydride functional polyorganosiloxanes (Component B) and then combining those blends together with other components to form the composition.
  • It is beneficial to prepare the blend of alkenyl functionalized polyorganosiloxanes (Component A) by introducing the resinous alkenyl functionalized polyorganosiloxane as a solution in a solvent, such as xylene, and then stripping the solvent from the blend. Introducing the resin as a solid, such as in flake form, in an effort to prepare Component A makes it difficult to prepare a homogenous blend suitable to achieve the performance described herein.
  • Curing the Composition
  • Cure compositions of the present invention by exposing the composition to a temperature for a period of time sufficient to accomplish cure. While cure can occur at a temperature as low as 25° C., it generally would require an undesirable long time to complete curing at 25° C. Typically, it is desirable to heat the composition to a temperature of 120° C. or more, preferably 130° C. or more, 140° C. or more, 150° C. or more, while at the same time a temperature that is generally 220° C. or less, 210° C. or less, 200° C. or less, 190° C. or less, 180° C. or less, even 170° C. or less in order to more rapidly cure the composition. For example, evaluation of T90 requires heating the composition to 150° C. and as FIG. 1 illustrates, composition strength nearly levels off (an indication of complete reaction) within 10 minutes.
  • Suitable methods of mixing components of the present invention to form a composition include adding the component together and agitating with a spatula, a drum roller, a mechanical stirrer, a three-roll mill, a sigma blade mixer, a bread dough mixer or a two-roll mill.
  • Suitable methods for heating the composition to accelerate curing include heating in any manner including heating through processes such as injection molding, encapsulation molding, press molding, dispenser molding, extrusion molding, transfer molding, press vulcanization, centrifugal casting, calendaring, bead application or blow molding.
  • The composition of the present invention offers a means to decrease T90 while maintaining or increasing strength of the fully cured composition without having to increase catalyst or crosslinker concentration. As a result, clarity and colorless aspects of the resulting cured composition can remain high. The present composition can cure with reduced T90 and same or higher final modulus while still achieving a clear and/or colorless cured composition.
  • Evaluate relative T90 values to compositions having the same molar ratio of SiH to terminal alkenyl functionality. Decreased T90 values obtained by the present composition are evident relative to compositions having the same SiH to terminal alkenyl functionality molar ratio and the same hydrosilylation catalyst concentration.
  • The low T90 and high final modulus the composition of the present invention provides makes it ideal for injection molding applications. The low T90 and high final modulus allows parts to be released from the mold quicker than compositions having higher T90 values without experiences damage to the part because it is still malleable and curing. The rapid cure and high final modulus also makes the compositions of the present invention useful as coatings sealants, adhesives, mold making, encapsulants, lenses, and lightguides
  • Examples
  • Table 1 lists the materials for the Examples (Exs) and Comparative Examples (Comp Exs). “Me” refers to “methyl”, “Vi” refers to “vinyl”.
  • TABLE 1
    Component Description
    A1-1 Linear alkenyl functionalized polyorganosiloxane with a molecular formula of:
    (Me2ViSiO1/2)0.004(Me2SiO2/2)0.996. 61000 Daltons weight-average molecular weight;
    0.0048 mol % vinyl. Commercially available as “DMS-V41” from Gelest.
    A1-2 Linear alkenyl functionalized polyorganosiloxane with a molecular formula of:
    (Me2ViSiO1/2)0.004(Me2SiO2/2)0.996. 102000 weight-average molecular weight; 0.0033
    mol % vinyl. Commercially available as “DMS-V-51” from Gelest.
    A2-1 Resinous alkenyl functionalized polyorganosiloxane having the following formula:
    (ViMe2SiO1/2)0.04(Me3SiO1/2)0.40(SiO4/2)0.49(HO1/2)0.07 having a weight-average
    molecular weight of 6630 Daltons and a vinyl content of 0.070 mol %. Prepare
    according to the teachings of U.S. Pat. No. 2,676,182 as a 72 wt % solution in xylenes.
    A2-2 Resinous alkenyl functionalized polyorganosiloxane having the following formula:
    (ViMe2SiO1/2)0.09(Me3SiO1/2)0.42(SiO4/2)0.45(HO1/2)0.04 having a weight-average
    molecular weight of 3512 Daltons and a vinyl content of 0.115 mol %. Prepare
    according to the teachings of U.S. Pat. No. 2,676,182 as a 72 wt % solution in xylenes.
    B1-1 Linear alkenyl functionalized polyorganosiloxane having the following formula:
    (Me3SiO1/2)0.02(Me2SiO2/2)0.48(MeHSiO2/2)0.50 having 0.708 mol % of H and a D/DH
    mole ratio of 1. Prepare according to the teachings of U.S. Pat. No. 3,722,247.
    B1-2 Linear alkenyl functionalized polyorganosiloxane having the following formula:
    (Me3SiO1/2)0.14(Me2SiO2/2)0.60(MeHSiO2/2)0.26 having 0.361 mol % of H and a D/DH
    mole ratio of 2.4. Prepare according to the teachings of U.S. Pat. No. 3,722,247.
    B1-3 Linear alkenyl functionalized polyorganosiloxane having the following formula:
    (Me3SiO1/2)0.06(Me2SiO2/2)0.76(MeHSiO2/2)0.18 having a D/DH mole ratio of 4.2.
    Prepare according to the teachings of U.S. Pat. No. 3,722,247.
    B1-4 Linear alkenyl functionalized polyorganosiloxane having the following formula:
    (Me3SiO1/2)0.03(Me2SiO2/2)0.86(MeHSiO2/2)0.11 having a D/DH mole ratio of 8. Prepare
    according to the teachings of U.S. Pat. No. 3,722,247.
    B1-5 Linear alkenyl functionalized polyorganosiloxane having the following formula:
    (Me3SiO1/2)0.01(Me2SiO2/2)0.90(MeHSiO2/2)0.09 having 0.113 mol % of H and a D/DH
    mole ratio of 10.6. Prepare according to the teachings of U.S. Pat. No. 3,722,247.
    B1-6 Linear alkenyl functionalized polyorganosiloxane having the following formula:
    (Me3SiO1/2)0.02(Me2SiO2/2)0.91(MeHSiO2/2)0.07 having 0.100 mol % of H and a D/DH
    mole ratio of 13.1. Prepare according to the teachings of U.S. Pat. No. 3,722,247.
    B2 Resinous silyl hydride functionalized polyorganosiloxane having the following formula:
    (HMe2SiO1/2)0.02(Me2SiO1/2)0.62(SiO4/2)0.30 having 0.950 mol % H. Prepare according
    to the teachings of U.S. Pat. No. 4,774,310.
    C Karstedt's catalyst: Platinum(0)-1,3-divinyl-1,1,3,3-tetramethyldisiloxane.
    Commercially available from Sigma-Aldrich.
    D1 Inhibitor 1-ethynyl-1-cyclohexanol. Commercially available from Sigma-Aldrich.
    D2 Inhibitor 3,5-dimethyl-1-hexyn-3-ol. Commercially available as Surfynol ™ 61
    (Surfynol is a trademark of Evonik Degussa GmbH).
  • Prepare formulations according to the recipes in the tables below. In general, prepare the formulations by combining the A2 component with the A1 component in solvent (xylene) and then stripping the solvent using a rotary evaporator at 1.3 megapascals (10 Torr) and 160° C. for one hour. The solvent should be less than 0.3 wt % of the mixture as confirmed by non-volatile content (NVC) testing (Conduct NVC testing by dispensing 10 g of the mixture onto an aluminum tray, measuring the total weight with a digital scale, heating the sample at 150° C. for 2 hours and then reweighing the sample to measure mass loss). After removal of solvent, add the mixture of the A1 and A2 components to a mixing cup (FlackTec Max 100, clear) at the loading required for the recipe. Add in sequential order the Component C, Component D, Component B1 and then Component B2, with hand mixing after addition of each component using a metal spatula or glass stir rod. Following addition of all components, cap the mixing cup with a screw top lid and mix by asymmetric centrifugal mixing using a FlackTek SpeedMixer DAC 150.1 FVZ at 3,000 revolutions per minute for 25 seconds.
  • Evaluate optical properties of the formulations in the following manner. Pour a sample of the formulation into a polystyrene cuvette of dimensions 3.2 centimeters by 2 centimeters by 5 centimeters (Konica Minolta, Sensing Plastic Cell CM-A132 Part No. 1870-717). Cure the sample in an oven at 80° C. for 24 hours. Remove the cured sample from the cuvette and post cure at 150° C. for one hour. Measure optical properties of the post-cured sample using a Perkin Elmer Lambda 950 spectrophotometer equipped with a 150 millimeter integrating sphere. Operate the spectrophotometers at a scan speed of 250 nanometers per minute using a one nanometer slit width over a wavelength range of 200-800 nanometers. Obtain optical transmittance of the samples as described in ASTMD1003. Calculate Δu′v′ from the transmittance spectra as described in CIE 1976 standard. Report transmittance data with reflection losses (Fresnel reflections).
  • Data for FIG. 1
  • Table 1 contains the weight-parts of each component in the formulations for Comparative Example (Comp Ex) A, Comp Ex B and Example (Ex) 1.
  • TABLE 1
    Component/Characteristic Comp Ex A Comp Ex B Ex 1
    A1-1 (wt parts) 46.52 51.50 50.40
    A2-1 (wt parts) 38.06 42.10 41.23
    B1-2 (wt parts) 15.22 0 3.27
    B2 (wt parts) 0 6.24 4.90
    C (wt parts) 0.060 0.060 0.060
    D1 (wt parts) 0.15 0.14 0.14
    H:Vi molar ratio 1.8 1.8 1.8
    Catalyst (ppm) 3 3 3
    D/DH molar ratio in B1 2.4 0 2.4
    T90 (seconds) 376.9 389 266.5
    Final torque-modulus (dNm) 8.52 57.6 57.6
  • FIG. 1 provides in illustration form the strength of the composition as the reaction progresses. The large symbol for each set of data corresponds to the T90 value for the run. As shown in the curves of FIG. 1 and the data of Table 1, when the composition lacks linear silyl hydride functionalized polyorganosiloxane (see Comp Ex B) then the formulation not only has a relatively long T90 but fails to achieve a final strength even close to the other compositions. When the composition lacks a resinous silyl hydride functionalized polyorganosiloxane (see Comp Ex A) then the formulation has a relative long T90 even though it eventually reaches a similar composition strength as Ex 1. Ex 1 illustrates that when both the linear and resinous silyl hydride functionalize polyorganosiloxanes are present the composition quickly builds strength and has a relatively short T90.
  • Effect of Increasing Catalyst Rather than Adding Linear SiH
  • Comp Exs C and D illustrate the effect of increasing catalyst concentration to a composition comprising linear and resinous alkenyl functionalized polyorganosiloxanes and resinous silyl hydride functionalized polyorganosiloxanes. Table 2 presents the weight-parts of each component in Comp Exs C and D as well as the characteristics of the resulting compositions. Comp Ex D contains 3 times the amount of catalyst relative to Comp Ex C and results in a higher aged Δu′v′, corresponding to a reduction in optical quality.
  • TABLE 2
    Component/Characteristic Comp Ex C Comp Ex D
    A1-2 (wt parts) 69.63 69.63
    A2-1 (wt parts) 27.08 27.08
    B2 (wt parts) 3.09 3.09
    C (wt parts) 0.060 0.060
    D2 (wt parts) 0.1 0.1
    H:Vi molar ratio 1.4 1.4
    Catalyst (ppm) 3.1 9.3
    T90 (seconds) 394.4 320.26
    Final torque-modulus (deciNewton 16.98 20.08
    Meters(dNm))
    Initial % Transmittance at 400 nm 88.30 88.35
    Initial Δu′v′ at 3.2 cm path length 0.0016 0.0016
    150 C. 200 hours aged Δu′v′ 0.0069 0.0167
  • Effect of Increasing SiH Concentration Rather than Adding Linear SiH
  • Comp Exs E and F illustrate the effect of increasing resinous silyl hydride functionalized polyorganosiloxane (increasing resinous crosslinker concentration). Table 3 presents the weight-parts of each component in Comp Exs E and F and characteristics of the resulting compositions. Increasing resinous crosslinker results in a decreased initial % transmittance at 400 nm and aged Δu′v′, corresponding less transparency.
  • TABLE 3
    Component/Characteristic Comp Ex C Comp Ex D
    A1-1 (wt parts) 41.86 40.8
    A1-2 (wt parts) 13.75 13.36
    A2-1 (wt parts) 39.59 38.58
    B2 (wt parts) 4.6 7.0
    C (wt parts) 0.06 0.06
    D2 (wt parts) 0.2 0.2
    H:Vi molar ratio 1.4 2.2
    Catalyst (ppm) 3.1 3.1
    Initial % Transmittance at 400 nm 87.3 81.9
    Initial Δu′v′ at 3.2 cm path length 0.0018 0.0038
    150 C. 200 hours aged Δu′v′ 0.0017 0.0055
  • Further Demonstrations of the Present Invention
  • The following data illustrates the beneficial results obtained by compositions of the present invention upon curing the composition. In particular, faster T90 values and equal or greater final modulus values are achieved relative to similar compositions with only resinous silyl-hydride functional crosslinkers over a broad range of silyl hydride-to-alkenyl ratios, demonstrating the surprising effect of adding linear crosslinker has in the present invention. This result is obtained over a broad range of silyl hydride-to alkenyl ratios when the wt % of linear silyl hydride functionalized polyorganosiloxane relative to all silyl hydride functionalized polyorganosiloxanes is greater than 10 wt % and less than 50 wt % and the ratio of D/DH for the silyl hydride functionalized polyorganosiloxane is greater than 2 and less than 14.
  • Tables 4-6 present formulations and results for samples with a variety of D/DH ratios at three different silyl hydride-to alkenyl ratios, each using A2-1 as the resinous alkenyl functionalized polyorganosiloxane. Formulations show the weight-parts of each component in the composition.
  • Similarly, Table 7 presents formulations and results for samples with a variety of D/DH ratios at three different silyl hydride-to-alkenyl ratios, each using A2-2 as the resinous alkenyl functionalized polyorganosiloxane.
  • Samples identified as Examples (Exs) show decreased T90 value and similar or higher final torque-modulus relative to the reference (formulation without linear crosslinker) over all of the silyl hydride-to-alkenyl ratios—demonstrating the unexpected impact of adding the linear crosslinker over a broad range of silyl hydride-to-alkenyl ratios. While some of the samples marked as Comparative Examples (Comp Exs) demonstrate decreased T90 and similar or higher final torque-modulus relative to the reference in one or some of the silyl hydride-to-alkenyl ratios they do not demonstrate such properties over all silyl hydride-to alkenyl ratios.
  • TABLE 4
    Resin A2-1 with SiH:alkenyl molar ratio of 1.2
    Compo-
    nent/Char- Comp Ex C Comp Comp Comp Comp Comp
    acteristic (Reference) Ex 2 Ex 3 Ex4 Ex 5 Ex 6 Ex 7 Ex 8 Ex D Ex E Ex F Ex G Ex H
    A1-1 52.55 52.26 52.22 52.14 52.05 51.97 51.65 51.33 52.23 52.40 51.30 52.34 52.33
    A2-1 42.99 42.75 42.72 42.66 42.59 42.52 42.26 41.99 42.74 42.87 41.97 42.82 42.81
    B1-1 2.42
    B1-2 1.25 0.45
    B1-3 0.77 1.29 2.36 3.26
    B1-4 1.33
    B1-5 0.73 0.46
    B1-6 2.59 0.47
    B2 4.26 4.02 4.13 3.75 3.87 3.98 3.53 3.89 2.42 4.07 3.26 4.18 4.19
    C 0.060 0.060 0.060 0.060 0.060 0.060 0.060 0.060 0.060 0.060 0.060 0.060 0.060
    D1 0.14 0.14 0.14 0.14 0.14 0.14 0.14 0.14 0.14 0.14 0.14 0.14 0.14
    D/DH ratio N/A 4.2 10.6 2.4 4.2 8.0 4.2 13.1 1.0 2.4 4.2 10.6 13.1
    Wt % B1 0 16 15 25 25 25 40 40 50 10 50 10 10
    relative
    to sum of
    B1 and B2
    T90 (s) 479 452 461 406 438 448 402 444 416 454 395 472 464
    Final 26.6 27.5 26.8 26.9 27.4 26.5 26.9 27.0 20.9 26.6 24.5 26.1 24.6
    Torque-
    Modulus
    (dNm)
  • TABLE 5
    Resin A2-1 with SiH:alkenyl molar ratio of 1.7
    Compo-
    nent/Char- Comp Ex I Ex Ex Ex Ex Ex Ex Ex Comp Comp Comp Comp Comp
    acteristic (Reference) Ex 9 10 11 12 13 14 15 16 Ex J Ex K Ex L Ex M Ex N
    A1-1 51.63 51.23 51.12 51.07 50.96 50.83 50.79 50.40 49.97 51.56 51.34 49.94 49.48 49.32
    A2-1 42.25 41.92 41.87 41.78 41.69 41.59 41.56 41.24 40.88 42.18 42.01 40.86 40.48 40.35
    B1-1 0.61
    B1-2 1.74
    B1-3 1.06 1.79 3.26 4.5
    B1-4 1.84 0.64 4.92
    B1-5 1.01 1.86 5.07
    B1-6 3.58
    B2 5.92 5.59 5.73 5.21 5.36 5.53 5.59 4.89 5.37 5.45 5.80 4.50 4.92 5.07
    C 0.60 0.60 0.60 0.60 0.60 0.60 0.60 0.60 0.60 0.60 0.60 0.60 0.60 0.60
    D1 0.14 0.14 0.14 0.14 0.14 0.14 0.14 0.14 0.14 0.14 0.14 0.14 0.14 0.14
    D/DH ratio N/A 4.2 10.6 2.4 4.2 8.0 10.6 4.2 13.1 1.0 8.0 4.2 8.0 10.6
    Wt % B1 0 16 15 25 25 25 25 40 40 10 10 50 50 50
    relative
    to sum of
    B1 and B2
    T90 (s) 434 368 402 313 351 360 367 319 365 431 375 314 320 333
    Final 53.0 56.8 54.8 58.3 58.8 56.9 56.3 54.9 53.5 52.7 59.0 51.1 53.6 54.8
    Torque-
    Modulus
    (dNm)
  • TABLE 6
    Resin A2-1 with SiH:alkenyl molar ratio of 2.2
    Compo-
    nent/Char- Comp Ex O Ex Ex Ex Ex Ex Ex Ex Comp Comp Comp Comp Comp Comp
    acteristic (Reference) 17 18 19 20 21 22 23 Ex P Ex Q Ex R Ex S Ex T Ex U
    A1-1 50.75 50.24 50.17 50.50 50.05 49.73 49.21 48.67 50.65 50.45 50.38 50.37 49.06 48.63
    A2-1 41.53 41.11 41.05 41.31 40.95 40.69 40.27 39.82 41.44 41.28 41.22 41.22 40.14 39.79
    B1-1 2.00 0.77
    B1-2 2.20 5.30
    B1-3 1.35 4.13 0.81 5.69
    B1-4 2.35
    B1-5 1.29 0.82
    B1-6 4.52 0.82
    B2 7.52 7.09 7.30 5.99 6.61 7.03 6.19 6.79 6.94 7.27 7.38 7.38 5.30 5.69
    C 0.60 0.60 0.60 0.60 0.60 0.60 0.60 0.60 0.60 0.60 0.60 0.60 0.60 0.60
    D1 0.14 0.14 0.14 0.14 0.14 0.14 0.14 0.14 0.14 0.14 0.14 0.14 0.14 0.14
    D/DH ratio N/A 4.2 10.6 1 2.4 8.0 4.2 13.1 1.0 4.2 10.6 13.1 2.4 4.2
    Wt % B1 0 16 15 25 25 25 40 40 10 10 10 10 50 50
    relative
    to sum of
    B1 and B2
    T90 (s) 375 265 288 307 234 240 238 263 357 289 296 296 189 220
    Final 59.0 66.6 64.2 65.8 64.0 65.1 63.7 60.7 64.9 67.4 64.7 66.3 53.0 59.6
    Torque-
    Modulus
    (dNm)
  • TABLE 7
    Resin A2-2 at various SiH:alkenyl molar ratios
    Compo- 1.2 SiH: Alkenyl Ratio 1.6 SiH:Alkenyl Ratio 1.8 SiH:Alkenyl Ratio
    nent/Chara- Comp Ex V Ex Comp Comp Ex X Comp Comp Comp Ex AA Comp Comp Comp
    cteristic (Reference) 24 Ex W (Reference) Ex 25 Ex Y Ex Z (Reference) Ex AA Ex AA Ex AA
    A1-2 46.35 45.29 46.14 45.28 43.92 43.82 45.01 44.76 44.46 43.28 42.38
    A2-2 46.35 45.29 46.14 45.28 43.92 43.82 45.01 44.76 44.46 43.28 42.38
    B1-2 0.75 3.69 4.79 0.98 1.09 8.3
    B1-5 3.65 6.02
    B2 7.09 5.53 6.76 9.25 7.18 8.52 8.80 10.28 9.79 7.95 9.02
    C 0.06 0.060 0.060 0.060 0.060 0.060 0.060 0.060 0.060 0.060 0.060
    D1 0.14 0.14 0.14 0.14 0.14 0.14 0.14 0.14 0.14 0.14 0.14
    D/DH ratio N/A 2.4 2.4 N/A 2.4 10.6 2.4 N/A 2.4 2.4 10.6
    Wt % B1 0 40 10 0 40 30 10 0 10 40 40
    relative
    to sum of
    B1 and B2
    T90 (s) 462 388 441 319 244 385 233 94 69 210 139
    Final 50.0 51.4 53.3 84.0 90.1 73.7 86.5 80.3 84.2 96.9 82.5
    Torque-
    Modulus
    (dNm)

Claims (10)

1. A composition comprising:
(A) a blend of alkenyl functionalized polyorganosiloxanes, the blend consisting of:
(i) a linear alkenyl functionalized polyorganosiloxane having the following formula:

(R3SiO1/2)1−a(R′2SiO2/2)a
where: at least one R in each (R3SiO1/2) unit is selected from C1-8 terminal alkenyl groups; subscript a has a value in a range of 0.333 to 0.999; and wherein the linear alkenyl functionalized polyorganosiloxane has a weight-average molecular weight of 260-155,000 Daltons as determined by gel permeation chromatography; and
(ii) a resinous alkenyl functionalized polyorganosiloxane having the following formula:

(R3SiO1/2)b(SiO4/2)c(HO1/2)d
where: at least two R groups in each molecule are selected from C1-8 terminal alkenyl groups; subscript b has a value in a range of 0.35-0.55; subscript c has a value in a range of 0.46-0.55; subscript d has a value in a range of 0.04 to 0.11; where the sum of subscripts b, c and d is one; the weight-average molecular weight of the resinous alkenyl functionalized polyorganosiloxane is in a range of 3,000 to 30,000 Daltons as determined by GPC;
where the total concentration of C1-8 terminal alkenyl groups in the blend of alkenyl functionalized polyorganosiloxanes is in a range of 2.5 to 13.5 mole-percent relative to total moles of polyorganosiloxanes in the blend of alkenyl functionalized polyorganosiloxanes; and
(B) a blend of silyl hydride functionalized polyorganosiloxanes, the blend consisting of:
(i) a linear silyl hydride functionalized polyorganosiloxane having the following formula:

(R′3SiO1/2)1−(e+f)(R′2SiO2/2)e(R″HSiO2/2)f
where: the sum of subscripts e and f is in a range of 0.50 to 0.999; the ratio of subscripts e/f is greater than 2.0 and less than 14.0; wherein the linear silyl hydride functionalized polyorganosiloxane has a silicon hydride concentration in a range of 6 to 45 mole-percent relative to moles of the linear silyl hydride functionalized polyorganosiloxane; and a weight-average molecular weight in a range of 350 to 60,000 Daltons as determined by GPC, and is present at a concentration of more than 10 weight-percent and less than 50 weight-percent of weight of the blend of silyl hydride functionalized polyorganosiloxanes; and
(ii) a resinous silyl hydride functionalized polyorganosiloxane having the following formula:

(R′″2HSiO1/2)g(R′2SiO2/2)h(SiO4/2)i
where: subscript g has a value in a range of 0.5 to 0.7; subscript h has a value in a range of 0.01 to 0.03; subscript i has a value in a range of 0.27 to 0.51 where the sum of subscripts g, h and i is one; wherein the resinous silyl hydride functionalized polyorganosiloxane has a silicon hydride concentration in a range of 50 to 75 mole-percent relative to moles of resinous silyl hydride functionalized polyorganosiloxane; and having a weight-average molecular weight in a range of 500 to 1,500 Daltons as determined by GPC; and
(C) a hydrosilylation catalyst at a concentration of 2 to 6 weight-parts per million weight parts of the composition;
wherein:
R is independently in each occurrence selected from a group consisting of phenyl, hydroxyl, C1-8 alkyl, and C1-8 terminal alkenyl groups;
R′ is independently in each occurrence selected from a group consisting of phenyl and C1-8 alkyl groups;
R″ and R′″ independently in each occurrence selected from a group consisting of hydrogen and C1-8 alkyl groups;
subscripts a-i are mole-ratios for the corresponding siloxane units relative to total siloxane units in the molecule; and
the concentration of Component (A)(i) is in a range of 25 to 80 weight-percent; Component (A)(ii) is in a range of 25 to 70 weight-percent; Component (B)(i) is in a range of 0.2 to 15 weight-percent; and Component (B)(ii) is in a range of 1.0 to 10 weight-percent; with weight-percent relative to combined weight of Components (A)(i), (A)(ii), (B)(i) and (B)(ii); and the molar ratio of silyl hydride hydrogens to the sum of terminal alkenyl functionality on alkenyl functionalized polyorganosiloxane in the composition is in a range of 1.2 to 2.2.
2. The composition of claim 1, wherein the resinous alkenyl functionalized polyorganosiloxane of (A)(ii) is selected from a group consisting of alkenyl functionalized polyorganosiloxanes where subscript b is in a range of 0.35 to 0.47 and alkenyl functionalized polyorganosiloxanes where subscript b is in a range of 0.48 to 0.55.
3. The composition of claim 1, wherein the composition further comprises 0.1 to 1.0 weight-percent of acetylenic alcohol based on composition weight.
4. The composition of claim 1, wherein the concentration of hydrosilylation catalyst is in a range of 2 to 4 weight-parts per million weight parts of the composition.
5. The composition of claim 1, wherein the terminal alkenyl groups are vinyl groups.
6. The composition of claim 1, wherein each is R independently in each occurrence selected from a group consisting of methyl, vinyl, and phenyl groups; R′ is independently in each occurrence selected from a group consisting of methyl and phenyl groups; R″ is methyl; and R′″ is independently in each occurrence selected from a group consisting of hydrogen and methyl groups.
7. The composition of claim 1, wherein the molar ratio of silyl hydride hydrogens to the sum of terminal alkenyl and hydroxyl groups in the composition is in a range of 1.2 to 1.7.
8. The composition of claim 1, wherein the composition is free of silica particles.
9. A method for curing the composition of claim 1, the method comprising the steps: (i) providing the composition of any one previous claim; and (ii) heating the composition to a temperature in a range of 120 to 220 degrees Celsius.
10. The method of claim 9, wherein the heating of the composition occurs during a process selected from a group consisting of: injection molding processes, encapsulation molding processes, press molding processes, dispenser molding processes, extrusion molding processes, transfer molding processes, transfer molding processes, press vulcanization processes, centrifugal casting processes, calendaring processes, bead application processes and blow molding processes.
US17/761,269 2019-12-11 2020-12-02 Rapid hydrosilylation cure composition Active US11492449B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US17/761,269 US11492449B1 (en) 2019-12-11 2020-12-02 Rapid hydrosilylation cure composition

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962946449P 2019-12-11 2019-12-11
US17/761,269 US11492449B1 (en) 2019-12-11 2020-12-02 Rapid hydrosilylation cure composition
PCT/US2020/062788 WO2021118837A1 (en) 2019-12-11 2020-12-02 Rapid hydrosilylation cure composition

Publications (2)

Publication Number Publication Date
US20220348723A1 true US20220348723A1 (en) 2022-11-03
US11492449B1 US11492449B1 (en) 2022-11-08

Family

ID=74626076

Family Applications (1)

Application Number Title Priority Date Filing Date
US17/761,269 Active US11492449B1 (en) 2019-12-11 2020-12-02 Rapid hydrosilylation cure composition

Country Status (8)

Country Link
US (1) US11492449B1 (en)
EP (1) EP4073143B1 (en)
JP (1) JP7214924B2 (en)
KR (1) KR102512590B1 (en)
CN (1) CN114787242B (en)
CA (1) CA3161291C (en)
TW (1) TW202122496A (en)
WO (1) WO2021118837A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023191962A1 (en) * 2022-03-28 2023-10-05 Rohm And Haas Company Rapid low temperature curing moldable silicone compositions

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20170087351A1 (en) * 2011-01-27 2017-03-30 Medtronic, Inc. Anchors including rigid bodies defining full length slots for use with implantable medical leads

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2676182A (en) 1950-09-13 1954-04-20 Dow Corning Copolymeric siloxanes and methods of preparing them
US3220972A (en) 1962-07-02 1965-11-30 Gen Electric Organosilicon process using a chloroplatinic acid reaction product as the catalyst
US3159601A (en) 1962-07-02 1964-12-01 Gen Electric Platinum-olefin complex catalyzed addition of hydrogen- and alkenyl-substituted siloxanes
US3296291A (en) 1962-07-02 1967-01-03 Gen Electric Reaction of silanes with unsaturated olefinic compounds
NL131800C (en) 1965-05-17
US3516946A (en) 1967-09-29 1970-06-23 Gen Electric Platinum catalyst composition for hydrosilation reactions
FR2085315B1 (en) 1970-04-08 1973-07-13 Aerospatiale
US3814730A (en) 1970-08-06 1974-06-04 Gen Electric Platinum complexes of unsaturated siloxanes and platinum containing organopolysiloxanes
US3989668A (en) 1975-07-14 1976-11-02 Dow Corning Corporation Method of making a silicone elastomer and the elastomer prepared thereby
GB8615862D0 (en) 1986-06-28 1986-08-06 Dow Corning Ltd Making siloxane resins
US4766176A (en) 1987-07-20 1988-08-23 Dow Corning Corporation Storage stable heat curable organosiloxane compositions containing microencapsulated platinum-containing catalysts
US4784879A (en) 1987-07-20 1988-11-15 Dow Corning Corporation Method for preparing a microencapsulated compound of a platinum group metal
JP2630993B2 (en) 1988-06-23 1997-07-16 東レ・ダウコーニング・シリコーン株式会社 Granules containing platinum-based catalyst for hydrosilylation reaction and method for producing the same
JPH0214244A (en) 1988-06-30 1990-01-18 Toray Dow Corning Silicone Co Ltd Thermosetting organopolysiloxane composition
US5036117A (en) 1989-11-03 1991-07-30 Dow Corning Corporation Heat-curable silicone compositions having improved bath life
GB9103191D0 (en) 1991-02-14 1991-04-03 Dow Corning Platinum complexes and use thereof
JP5680889B2 (en) * 2010-06-29 2015-03-04 東レ・ダウコーニング株式会社 Curable organopolysiloxane composition and optical semiconductor device
WO2012084992A1 (en) * 2010-12-21 2012-06-28 Bluestar Silicones France Sas Silicon composition that is cross-linkable by hydrosilylation, and method for coating or manufacturing objects using said composition
WO2014017579A1 (en) 2012-07-25 2014-01-30 住友ベークライト株式会社 Silicone rubber-based curable composition
JP2015523414A (en) 2012-07-30 2015-08-13 東レ・ダウコーニング株式会社 2 parts curable liquid silicone rubber composition
EP2910606B1 (en) 2012-10-22 2020-09-09 JNC Corporation Thermosetting resin composition
US10155885B2 (en) * 2014-08-06 2018-12-18 Dow Corning Corporation Organosiloxane compositions and uses thereof
US20200239687A1 (en) * 2015-11-18 2020-07-30 Dow Silicones Corporation Curable silicone composition
GB201603107D0 (en) 2016-02-23 2016-04-06 Dow Corning Low temperature cure silicone elastomer
WO2017143508A1 (en) 2016-02-23 2017-08-31 Dow Corning Corporation Curable high hardness silicone composition and composite articles made thereof
WO2017147061A1 (en) 2016-02-23 2017-08-31 Dow Corning Corporation Selective adhesion silicone rubber
JP6634988B2 (en) * 2016-09-20 2020-01-22 信越化学工業株式会社 Transparent liquid silicone rubber composition
WO2018155131A1 (en) * 2017-02-27 2018-08-30 東レ・ダウコーニング株式会社 Curable organopolysiloxane composition and semiconductor device

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20170087351A1 (en) * 2011-01-27 2017-03-30 Medtronic, Inc. Anchors including rigid bodies defining full length slots for use with implantable medical leads

Also Published As

Publication number Publication date
CN114787242A (en) 2022-07-22
CN114787242B (en) 2023-04-18
EP4073143B1 (en) 2024-03-06
JP7214924B2 (en) 2023-01-30
KR20220084433A (en) 2022-06-21
US11492449B1 (en) 2022-11-08
CA3161291A1 (en) 2021-06-17
TW202122496A (en) 2021-06-16
KR102512590B1 (en) 2023-03-23
CA3161291C (en) 2023-03-14
EP4073143A1 (en) 2022-10-19
WO2021118837A1 (en) 2021-06-17
JP2022551336A (en) 2022-12-08

Similar Documents

Publication Publication Date Title
TWI617642B (en) Moisture-curable hot melt silicone adhesive compositions including an alkoxy-functional siloxane reactive resin
TWI613258B (en) Alkoxy-functional organopolysiloxane resin and polymer and related methods for forming same
KR100492650B1 (en) Double Curing Fluid Adhesive
US11492449B1 (en) Rapid hydrosilylation cure composition
EP3808799A1 (en) Manufacturing method for cured silicone product, cured silicone product, and optical member
CN114302917B (en) Dual cure composition
EP3673015B1 (en) Injection moldable silicone composition
JP2022010421A (en) Polyorganosiloxane, polyorganosiloxane composition and cured product thereof
US20220213273A1 (en) Anhydride and aromatic functionalized polyorganosiloxanes
US11370936B2 (en) Polyaddition-crosslinking silicone composition that is useful for the overmoulding of parts
CA2036095C (en) Curable composition
WO2023191962A1 (en) Rapid low temperature curing moldable silicone compositions
EP3868831B1 (en) Addition-curable liquid silicone rubber composition for led headlamps, and led headlamp
EP3559117B1 (en) Curable silicone composition
JP2024127914A (en) Organopolysiloxane composition
JP2022084448A (en) Silicone composition, distributed composition of curable silicone composition and manufacturing method of cured product thereof and cured product to be obtained, and light transmittance adjustment method
JP2024120969A (en) Organopolysiloxane composition
WO2023164018A1 (en) Curable silicone composition and cured product thereof
CN113260659A (en) Curable silicone composition and cured product thereof
EP2412745A1 (en) Composition for thermoplastic silicone resin

Legal Events

Date Code Title Description
FEPP Fee payment procedure

Free format text: ENTITY STATUS SET TO UNDISCOUNTED (ORIGINAL EVENT CODE: BIG.); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY

AS Assignment

Owner name: DOW SILICONES CORPORATION, MICHIGAN

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:CUMMINGS, MICHELLE;SUHR, JASON D.;TUFT, BRADLEY W.;AND OTHERS;SIGNING DATES FROM 20200109 TO 20200114;REEL/FRAME:061290/0727

Owner name: DOW GLOBAL TECHNOLOGIES LLC, MICHIGAN

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:MCDONALD, JOEL P.;CLARK, BRIAN;SIGNING DATES FROM 20200110 TO 20200113;REEL/FRAME:061591/0585

STCF Information on status: patent grant

Free format text: PATENTED CASE